V. Camus, Manifestations psychiatriques des tumeurs cérébrales : approche clinique et thérapeutique. EMC Psychiatrie, vol.1, pp.1-3, 2004.

A. R. Feinstein, The Pre-therapeutic classification of comorbidity in chronic disease, J Chronic Dis. déc, vol.23, issue.7, p.45568, 1970.

M. H. Kaplan and A. R. Feinstein, The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus, J Chronic Dis. sept, vol.27, issue.7-8, pp.387-404, 1974.

C. Murray and A. D. Lopez, The Global Burden of Disease : A compréhensive assessment of mortality and disability from diseases, injuries, and risk factors in, vol.2020, 1990.

M. A. Cambridge, , 1996.

J. F. Goldberg and C. L. Ernst, Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder, J Clin Psychiatry, vol.63, issue.11, pp.985-91, 2002.

R. Hirschfeld, L. Lewis, and L. A. Vornik, Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder, J Clin Psychiatry. févr, vol.64, issue.2, pp.161-74, 2003.

W. W. Eaton, C. E. Holzer, V. Korff, M. Anthony, J. C. Helzer et al., The design of the Epidemiologic Catchment Area surveys. The control and measurement of error. Arch Gen Psychiatry, vol.41, pp.942-950, 1984.

D. G. Blazer, R. C. Kessler, and K. A. Mcgonagle, The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey, Am J Psychiatry. juill, vol.151, issue.7, pp.979-86, 1994.

R. C. Kessler, P. Berglund, and O. Demler, The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R), JAMA. 18 juin, vol.289, issue.23, pp.3095-105, 2003.

D. S. Hasin, R. D. Goodwin, and F. S. Stinson, Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry, vol.62, pp.1097-106, 2005.

J. Alonso, M. C. Angermeyer, and S. Bernert,

, Acta Psychiatr Scand Suppl, issue.420, pp.21-28, 2004.

J. Lépine, I. Gasquet, and V. Kovess,

, L'Encephale. avr, vol.31, issue.2, pp.182-94, 2005.

J. M. Murphy, N. M. Laird, and R. R. Monson, et al Incidence of depression in the Stirling County Study: historical and comparative perspectives, Psychol Med. mai, vol.30, issue.3, pp.505-519, 2000.

M. M. Weissman, R. C. Bland, G. J. Canino, C. Faravelli, S. Greenwald et al., Crossnational epidemiology of major depression and bipolar disorder, JAMA. 24 juill, vol.276, issue.4, pp.293-302, 1996.

F. Rouillon, Epidémiologie des troubles psychiatriques, Ann Méd-Psychol, vol.166, pp.63-70, 2008.

F. Rouillon,

, L'Encephale. janv, vol.23, issue.1, pp.7-11, 1997.

F. Colom, E. Vieta, and C. Daban, Clinical and therapeutic implications of predominant polarity in bipolar disorder, J Affect Disord. juill, vol.93, issue.1-3, pp.13-20, 2006.

F. Colomb and E. Viela, Manuel de psychoéducation pour les bipolaires, traduction de Daban C, 2008.

A. R. Rosa, A. C. Andreazza, and M. Kunz, Predominant polarity in bipolar disorder: diagnostic implications, J Affect Disord. avr, vol.107, issue.1-3, pp.45-51, 2008.

R. C. Kessler, K. R. Merikangas, and P. S. Wang, Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century, Annu Rev Clin Psychol, vol.3, pp.137-58, 2007.

S. Zisook, A. J. Rush, and A. Albala, Factors that differentiate early vs. later onset of major depression disorder, Psychiatry Res. 15 déc, vol.129, issue.2, pp.127-167, 2004.

W. W. Eaton, D. A. Regier, and B. Z. Locke, The Epidemiologic Catchment Area Program of the National Institute of Mental Health, Public Health Rep, vol.96, issue.4, pp.319-344, 1981.

F. Bellivier, J. L. Golmard, and C. Henry, Admixture analysis of age at onset in bipolar I affective disorder, Arch Gen Psychiatry. mai, vol.58, issue.5, pp.510-512, 2001.
URL : https://hal.archives-ouvertes.fr/hal-02680140

F. Bellivier, J. L. Golmard, and M. Rietschel, Age at onset in bipolar I affective disorder: further evidence for three subgroups, Am J Psychiatry, vol.160, issue.5, pp.999-1001, 2003.

M. L. Bourgeois, C. Gay, and C. Henry, Les Troubles Bipolaires. Paris, Collection Psychiatrie, 2014.

, APA : American Psychiatric Association. DSM-IV-TR Manuel diagnostique et statistique des troubles mentaux, 2005.

R. H. Perlis, E. B. Dennehy, D. J. Miklowitz, M. P. Delbello, M. Ostacher et al., Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study, Bipolar Disord. juin, vol.11, issue.4, pp.391-400, 2009.

M. Strober, Relevance of early age-of-onset in genetic studies of bipolar affective disorder, J Am Acad Child Adolesc Psychiatry. juill, vol.31, issue.4, pp.606-616, 1992.

F. Schürhoff, F. Bellivier, R. Jouvent, M. C. Mouren-siméoni, M. Bouvard et al., Early and late onset bipolar disorders: two different forms of manic-depressive illness?, J Affect Disord. juin, vol.58, issue.3, pp.215-236, 2000.

A. González-pinto, A. Aldama, F. Mosquera, G. Gómez, and C. Epidemiology, diagnosis and management of mixed mania, CNS Drugs, vol.21, issue.8, pp.611-637, 2007.

C. F. Baldassano, L. B. Marangell, L. Gyulai, S. N. Ghaemi, H. Joffe et al., Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants, Bipolar Disord, vol.7, issue.5, pp.465-70, 2005.

L. L. Judd, H. S. Akiskal, P. J. Schettler, W. Coryell, J. Maser et al., The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?, J Affect Disord. janv, vol.73, issue.1-2, pp.19-32, 2003.

M. Sarron, C. Siobud-dorocant, and E. , Chelour Ellouz M. Apport des thérapies comportementales et cognitives dans les troubles bipolaires, vol.164, pp.341-348, 2006.

M. Olfson, A. K. Das, M. J. Gameroff, D. Pilowsky, A. Feder et al., Bipolar depression in a low-income primary care clinic, Am J Psychiatry, vol.162, issue.11, pp.2146-51, 2005.

R. H. Perlis, E. Brown, R. W. Baker, and A. A. Nierenberg, Clinical features of bipolar depression versus major depressive disorder in large multicenter trials, Am J Psychiatry. févr, vol.163, issue.2, pp.225-256, 2006.

M. A. Whooley, C. I. Kiefe, M. A. Chesney, J. H. Markovitz, K. Matthews et al., Depressive symptoms, unemployment, and loss of income: The CARDIA Study, Arch Intern Med. 9 déc, vol.162, issue.22, pp.2614-2634, 2002.

R. Elgie and P. L. Morselli, Social functioning in bipolar patients: the perception and perspective of patients, relatives and advocacy organizations -a review, Bipolar Disord. mars, vol.9, issue.1-2, pp.144-57, 2007.

D. A. Solomon, A. C. Leon, J. D. Maser, C. J. Truman, W. Coryell et al., Distinguishing bipolar major depression from unipolar major depression with the screening assessment of depression-polarity (SAD-P), J Clin Psychiatry. mars, vol.67, issue.3, pp.434-476, 2006.

A. Tylee, M. Gastpar, and J. Lépine, DEPRES II (depression research in European Society II) : A patient survey of the symptoms, disability and current management of depression in the community, International Clinical Psychopharmacology, vol.14, issue.3, pp.139-151, 1999.

, Épisode dépressif caractérisé de l'adulte : prise en charge en soins de premier recours, HAS, 2017.

H. S. Akiskal, P. Walker, V. R. Puzantian, D. King, T. L. Rosenthal et al., Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors, J Affect Disord. mai, vol.5, issue.2, pp.115-143, 1983.

M. M. Ohayon and A. F. Schatzberg, Prevalence of depressive episodes with psychotic features in the general population, Am J Psychiatry, vol.159, issue.11, pp.1855-61, 2002.

P. Mitchell, G. Parker, K. Jamieson, K. Wilhelm, I. Hickie et al., Are there any differences between bipolar and unipolar melancholia?, J Affect Disord. juin, vol.25, issue.2, pp.97-105, 1992.

C. L. Bowden, A different depression: clinical distinctions between bipolar and unipolar depression, J Affect Disord. févr, vol.84, issue.2-3, pp.117-142, 2005.

Z. Rihmer and K. Kiss, Bipolar disorders and suicidal behaviour, Bipolar Disord, vol.4, issue.1, pp.21-26, 2002.

X. Gonda, M. Pompili, G. Serafini, F. Montebovi, S. Campi et al., Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors, J Affect Disord, vol.143, issue.1-3, pp.16-26, 2012.

J. Lépine and M. Briley, The increasing burden of depression, Neuropsychiatr Dis Treat

F. K. Goodwin and K. R. Jamison, Manic-Depressive Illness : bipolar Disorders and Recurrent Depression, 2007.

J. Angst and R. Sellaro, Historical perspectives and natural history of bipolar disorder, Biol Psychiatry. 15 sept, vol.48, issue.6, pp.445-57, 2000.

M. Raja and A. Azzoni, Suicide attempts: differences between unipolar and bipolar patients and among groups with different lethality risk, J Affect Disord, vol.82, issue.3, pp.437-479, 2004.

G. Zalsman, M. Braun, M. Arendt, M. F. Grunebaum, L. Sher et al., A comparison of the medical lethality of suicide attempts in bipolar and major depressive disorders, Bipolar Disord, vol.8, issue.5, pp.558-65, 2006.

P. B. Mitchell, A. Frankland, D. Hadzi-pavlovic, G. Roberts, C. J. Wright et al., Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees, Br J Psychiatry J Ment Sci, vol.199, issue.4, pp.303-312, 2011.

F. Rouillon, I. Gasquet, and R. P. Garay, Prévalence des troubles bipolaires en médecine générale : enquête Bipolact Impact, Ann Méd Psychol, vol.167, pp.611-61, 2009.

K. R. Merikamgas, J. Angst, and W. Eaton, Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force, Br J Psychiatry Suppl, issue.30, pp.58-67, 1996.

C. Henry, D. Van-den-bulke, F. Bellivier, B. Etain, F. Rouillon et al., Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer, J Clin Psychiatry. mars, vol.64, issue.3, pp.331-336, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02672864

S. L. Mcelroy, L. L. Altshuler, T. Suppes, P. E. Keck, M. A. Frye et al., Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder, Am J Psychiatry. mars, vol.158, issue.3, pp.420-426, 2001.

R. S. El-mallakh and M. Hollifield, Comorbid anxiety in bipolar disorder alters treatment and prognosis, Psychiatr Q. juin, vol.79, issue.2, pp.139-50, 2008.

P. Gorwood and . Mise, Masques trompeurs et diagnostics différentiels du trouble bipolaire. L'Encéphale, vol.30, pp.182-193, 2004.

E. G. Hantouche and H. Akiskal, Reconnaître la bipolarité : son identité, sa fréquence et ses risques, Annales Médico Psychologiques, vol.162, pp.155-159, 2004.

M. L. Bourgeois, Aspects nosologiques des troubles bipolaires maniaco dépressifs. Considérations critique, Ann Méd Psychol, vol.167, pp.803-809, 2009.

B. Roshanaei-moghaddam and W. Katon, Premature mortality from general medical illnesses among persons with bipolar disorder: a review, Psychiatr Serv Wash DC. févr, vol.60, issue.2, pp.147-56, 2009.

C. U. Correll, Elevated cardiovascular risk in patients with bipolar disorder: when does it start and where does it lead?, J Clin Psychiatry. déc, vol.69, issue.12, pp.1948-52, 2008.

A. M. Kilbourne, N. E. Morden, K. Austin, M. Ilgen, J. F. Mccarthy et al., Excess heartdisease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors, Gen Hosp Psychiatry. déc, vol.31, issue.6, pp.555-63, 2009.

D. J. Kupfer, The increasing medical burden in bipolar disorder, JAMA. 25 mai, vol.293, issue.20, pp.2528-2558, 2005.

G. Maina, V. Salvi, A. Vitalucci, D. 'ambrosio, V. Bogetto et al., Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder, J Affect Disord. sept, vol.110, issue.1-2, pp.149-55, 2008.

H. Ey, P. Bernard, C. Brisset, . Manuel-de-psychiatrie, and . Masson, , p.1, 1960.

J. M. Léger, J. P. Clément, and J. Wertheimer, Chapitre histoire de la psychiatrie du sujet âgée par Berrios GE, pp.8-25, 1999.

J. Da-silva, M. Gonçalves-pereira, M. Xavier, and E. B. Mukaetova-ladinska, Affective disorders and risk of developing dementia: systematic review, Br J Psychiatry J Ment Sci. mars, vol.202, issue.3, pp.177-86, 2013.

K. Wu, C. Chang, H. Liang, C. Wu, C. Wu et al., Increased risk of developing dementia in patients with bipolar disorder: a nested matched case-control study, Bipolar Disord, vol.15, issue.7, pp.787-94, 2013.

L. V. Kessing and P. K. Andersen, Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?, J Neurol Neurosurg Psychiatry. déc, vol.75, issue.12, pp.1662-1668, 2004.

L. V. Kessing and F. M. Nilsson, Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses, J Affect Disord. févr, vol.73, issue.3, pp.261-270, 2003.

A. Pavlovic and J. Marley, Sivakumar Vet al . Development of frontotemporal dementia in a case of bipolar affective disorder: is there a link?, BMJ Case Rep. 2 févr, 2011.

D. Velakoulis, M. Walterfang, and M. Mocellin, Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases

F. Vorspan, M. Bertoux, and C. Brichant-petitjean, Relapsing-remitting behavioural variant of frontotemporal dementia in a bipolar patient, Funct Neurol. sept, vol.27, issue.3, pp.193-199, 2012.

C. Cerami, A. Marcone, and D. Galimberti, From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder, J Alzheimers Dis JAD, vol.27, issue.4, pp.791-798, 2011.

M. Hornberger, B. P. Shelley, and C. M. Kipps, Can progressive and non-progressive behavioural variant frontotemporal dementia be distinguished at presentation?, J Neurol Neurosurg Psychiatry. juin, vol.80, issue.6, pp.591-594, 2009.

R. R. Davies, C. M. Kipps, and J. Mitchell, Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging, Arch Neurol, vol.63, issue.11, pp.1627-1658, 2006.

C. Crump, K. Sundquist, M. A. Winkleby, and J. Sundquist, Comorbidities and mortality in bipolar disorder: a Swedish national cohort study, JAMA Psychiatry. sept, vol.70, issue.9, pp.931-940, 2013.

S. Guillaume, P. Courtet, and L. Samalin, Dépression bipolaire et conduites suicidaires

. L'encéphale, L'Encéphale, vol.3, pp.169-172, 2011.

M. Kédia, Y. Fliou, and . Bellivier, Conduites suicidaires et troubles bipolaires, Annales Médico Psychologiques, issue.170, pp.62-67, 2012.

F. Rouillon, I. Gasquet, and R. P. Garay, Prévalence des troubles bipolaires en médecine générale: enquête Bipolact Impact, Ann Méd Psychol, vol.167, pp.611-61, 2009.

P. F. Suvillan, N. C. Neale, and K. S. Kendler, Genetic epidemiology of major depressive disorder, Am J Psy, vol.157, pp.1552-62, 2000.

P. Mc-guffin, R. Katz, and P. Bebbington, Hazard, heredity and depression. A familly study, J Psy Res, vol.21, pp.365-75, 1987.

N. Ramoz and P. Gorwood, Génétique de la dépression, EMC Psychiatrie, vol.11, issue.3, pp.1-10, 2014.

A. D. Ogilvie, S. Battersby, and V. L. Bubb, Polymorphism in serotonin transporter gene associated with suceptibility to major depression, Lancet, vol.347, pp.731-734, 1996.

Z. Gao-j,-pan and Z. Jiao, TPH2 gene polymorphisms and major depression meta-analysis

, PlooS One, vol.7, p.36721, 2012.

T. Kishi, T. Tsunoka, and M. Ikeda, Serotonin 1A receptor gene and major depressive disorder : an association study and metana-analysis, J Hum Genet, vol.54, issue.11, pp.629-662, 2009.

M. Anguelova, C. Benkelfat, and G. Turecki, Asystematic rewiw of association studies investigating genes coding for serotonin receptors and the serotonin transporter : I. Affective disorders, Mol, vol.8, pp.574-91, 2003.

E. B. Binder, D. Salyakina, and P. Lichtner, Polymorphisms in FKBP5 are associated with increased recur-rence of depressive episodes and rapid response to antidepressant treatment

, Nat Genet, vol.36, pp.1319-1344, 2004.

M. Lekman, G. Laje, and D. Charney, The FKBP5-gene in depression and treatment response -an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort, Biol Psychiatry, vol.63, pp.1103-1113, 2008.

A. Zobel, A. Schuhmacher, and F. Jessen, DNA sequence variants of the FKBP5 gene are associated with unipolar depression, Int J Neuropsychopharmacol, vol.13, pp.649-60, 2010.

F. P. Velders, M. Kuningas, and M. Kumari, Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach, Psychoneuroendocrinology, vol.36, pp.1053-61, 2011.

Z. Liu, F. Zhu, and G. Wang, Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders, Neurosci Lett, vol.414, pp.155-163, 2007.

Y. Ishitobi, S. Nakayama, and K. Yamaguchi, Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population, Am J Med Genet B Neuropsychiatr Genet, vol.159, pp.429-465, 2012.

S. M. Villafuerte, J. Del-favero, and R. Adolfsson, Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression, Am J Med Genet, vol.114, pp.222-228, 2002.

E. F. Van-rossum, E. B. Binder, and M. Majer, Polymorphisms of the glucocorticoid recepto gene and major depression, Biol Psychiatry, vol.59, pp.681-689, 2006.

D. Vann-west, F. Van-den-eede, and J. Del-favero, Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression, Neuropsychopharmacology, vol.31, pp.620-627, 2006.

J. Schumacher, R. A. Jamra, and T. Becker, Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression, Biol Psychiatry, vol.58, pp.307-321, 2005.

A. S. Gonul, O. Kitis, and M. C. Eker, Association of the brain-derived neurotrophic factor Val66M et polymorphism with hippocampus volumes in drug-free depressed patients, World J Biol Psychiatry, vol.12, pp.110-118, 2011.

L. Pezawas, A. Meyer-lindenberg, and A. L. Goldman, Evidence of biologic epistasis between BDNF and SLC^A$ and implications for depression, Mol Psychiatry, vol.69, pp.762-71, 2011.

M. Verhagen, A. Van-der-meij, and P. A. Van-deurzen, Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity, Mol Psychiatry, vol.15, pp.260-71, 2010.

J. P. Gyekis, W. Yu, and S. Dong, No association of genetic variants in BDNF with major depression: a meta-and gene-based analysis, Am J Med Genet B Neuropsychiatr Genet, vol.162, pp.61-70, 2013.

C. Dong, M. L. Wong, and J. Licinio, Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans, Mol Psychiatry, vol.14, pp.1105-1123, 2009.

G. Juhasz, J. S. Dunham, and S. Mckie, The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions, Biol Psychiatry, vol.69, pp.762-71, 2011.

P. F. Sullivan, E. J. De-geus, and G. Willemsen, Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo, Mol Psychiatry, vol.14, pp.359-75, 2009.

P. Muglia, F. Tozzi, N. W. Galwey, and C. Francks, Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts, Mol Psychiatry, vol.15, pp.589-601, 2010.

C. M. Lewis, M. Y. Ng, and A. W. Butler, Genome-wide association study of major recurrent depression in the U.K. population, Am J Psychiatry, vol.167, pp.949-57, 2010.

M. Rietschel, M. Mattheisen, and J. Frank, Genome-wide association-, replication-, and neu-roimaging study implicates HOMER1 in the etiology of major depression, Biol Psychiatry, vol.68, pp.578-85, 2010.

J. Shi, J. B. Potash, and J. A. Knowles, Genome-wide association study of recurrent earlyonset major depressive disorder, Mol Psychiatry, vol.16, pp.193-201, 2011.

S. I. Shyn, J. Shi, J. B. Kraft, and J. B. Potash, Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies, Mol Psychiatry, vol.16, pp.202-217, 2011.

P. F. Sullivan, M. J. Daly, and M. O'donovan, Genetic architectures of psychiatric disorders: the emerging picture and its implications, Nat Rev Genet. 10 juill, vol.13, issue.8, pp.537-51, 2012.

J. W. Smoller and C. T. Finn, Family, twin, and adoption studies of bipolar disorder, Am J Med Genet C Semin Med Genet, vol.123, issue.1, pp.48-58, 2003.

F. Schu-rhoff, F. Bellivier, and R. Jouvent, Early and late onset bipolar disorders: Two different forms of manic depressive illness, Journal Aff Dis, vol.58, pp.215-236, 2000.

M. M. Weissman, P. Wickramaratne, and K. R. Merikangas, Onset of major depression in early adulthood. Increased familial loading and specificity, Arch Gen Psychiatry, vol.41, pp.1136-1179, 1984.

B. Etain, F. Mathieu, and M. Rietschel, Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early onset proband: Supportive evidence for linkage at 3p14, Mol Psychiatry, vol.11, pp.685-94, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00132874

N. Craddock and P. Sklar, Genetics of bipolar disorder, Lancet, vol.381, issue.9878, pp.1654-62, 2013.

A. E. Baum, N. Akula, and M. Cabanero, A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder, Mol Psychiatry, vol.13, pp.197-207, 2008.

G. Breen, D. St-clair, and C. S. , Well come Trust Case Control Consortium. Genomewide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, vol.447, issue.7145, pp.661-78, 2007.

P. Sklar, J. W. Smoller, J. Fan, and M. A. Ferreira, Whole-genome association study of bipolar disorder, Mol Psychiatry, vol.13, pp.558-69, 2008.

M. A. Ferreira, M. C. O'donovan, and Y. A. Meng, Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder, Nat Genet, vol.40, issue.9, pp.1056-1064, 2008.

P. H. Kuo, L. C. Chuang, and J. R. Liu, Identification of novel loci for bipolar I disorder in a multi-stage genome-wide association study, Prog Neuropsychopharmacol Biol Psychiatr y, vol.51, pp.58-64, 2014.

F. Bellivier, Genetic vulnerability factors in bipolar disorders, Annales Medico-Psychologiques, vol.167, pp.796-802, 2009.

V. Moskvina, N. Craddock, and P. Holmans, Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk, Mol Psychiatry. mars, vol.14, issue.3, pp.252-60, 2009.

E. Ivleva, G. Thaker, and C. A. Tamminga, Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder, Schizophr Bull. juill, vol.34, issue.4, pp.734-776, 2008.

P. Lichtenstein, B. H. Yip, and C. Björk, Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study, Lancet Lond Engl. 17 janv, vol.373, issue.9659, pp.234-243, 2009.

B. Millet, Psychosis and bipolar disorders neuro-imaging and genetics, Supplément, vol.5, pp.168-71, 2009.

R. Pidsley and J. Mill, Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research, Biol Psychiatry, vol.15, issue.2, pp.146-56, 2011.

M. Aas, B. Etain, and F. Bellivier, Additive effects of childhood abuse and cannabis abuse on clinical expressions of bipolar disorders, Psychol Med, vol.44, issue.8, pp.1653-62, 2014.

M. Szyf and . Epigenetics, DNA methylation, and chromatin modifying drugs, Annu Rev Pharmacol Toxicol, vol.49, pp.243-263, 2009.

J. M. Levenson and . Dna, cytosine-5) methyltransferase inhibitors: a potential therapeutic agent for schizophrenia, Mol Pharmacol, vol.71, issue.3, pp.635-642, 2007.

C. Heim, P. M. Plotsky, and C. B. Nemeroff, Importance of studying the contributions of early adverse experience to neurobiological findings in depression, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. avr, vol.29, issue.4, pp.641-649, 2004.

C. Heim and C. B. Nemeroff, Neurobiology of early life stress: clinical studies, Semin Clin Neuropsychiatry. avr, vol.7, issue.2, pp.147-59, 2002.

O. Agid, Y. Kohn, and B. Lerer, Environmental stress and psychiatric illness, Biomed Pharmacother, vol.54, issue.3, pp.135-176, 2000.

E. L. Weiss, J. G. Longhurst, and C. M. Mazure, Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates. m J Psychiatry, 1999.

P. E. Mullen, J. L. Martin, and J. C. Anderson, The long-term impact of the physical, emotional, and sexual abuse of children: A community study, Child Abuse Negl, vol.20, pp.7-21, 1996.

J. Mccauley, D. E. Kern, and K. Kolodner, Clinical characteristics of women with a history of childhood abuse: unhealed wounds, JAMA. 7 mai, vol.277, issue.17, pp.1362-1370, 1997.

J. M. Weiss, J. C. Stout, and M. F. Aaron, Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor, Brain Res Bull, vol.35, issue.5-6, pp.561-72, 1994.

L. Arborelius, M. J. Owens, and P. M. Plotsky, The role of corticotropin-releasing factor in depression and anxiety disorders, J Endocrinol. janv, vol.160, issue.1, pp.1-12, 1999.

C. O. Ladd, M. J. Owens, and C. B. Nemeroff, Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation, Endocrinology. avr, vol.137, issue.4, pp.1212-1220, 1996.

M. L. Price, A. L. Curtis, L. G. Kirby, R. J. Valentino, and I. Lucki, Effects of corticotropin-releasing factor on brain serotonergic activity, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. juin, vol.18, issue.6, pp.492-502, 1998.

L. S. Brady, H. J. Whitfield, and R. J. Fox, Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications, J Clin Invest, vol.87, pp.831-837, 1991.

L. S. Brady, P. Gold, and M. Herkenham, The antidepressants fluoxetine, idazoxan, and phenelzine alter corticotropin-releasing hormone and and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications, Brain Res, vol.572, pp.117-125, 1992.

D. Bellis, M. D. Gold, P. Geracioti, and T. D. , Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopression in patients with major depression, Am J Psychiatry, vol.150, pp.656-657, 1993.

D. Michelson, E. Galliven, and L. Hill, Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans, J Clin Endocrinol Metab, vol.82, pp.2601-2606, 1997.

R. C. Veith, N. Lewis, and J. I. Langohr, Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects, Psychiatry Res, vol.46, issue.1, pp.1-8, 1993.

B. G. Shapero, R. B. Weiss, and T. A. Burke, Kindling of Life Stress in Bipolar Disorder: Effects of Early Adversity, Behav Ther, vol.48, issue.3, pp.322-356, 2017.

N. Horesh and I. Iancu, A comparison of life events in patients with unipolar disorder or bipolar disorder and controls, Compr Psychiatry. avr, vol.51, issue.2, pp.157-64, 2010.

S. Nold, Prise en charge des dépressions pharmaco-résistantes associées à un stress professionnel. Thèse présentée le 24 octobre, 2018.

S. Rusinek, D. Servant, P. Graziani, and M. Hautekeete,

, L'Encephale. août, vol.25, issue.4, pp.358-63, 1999.

P. Graziani, S. Rusinek, D. Servant, and D. Hautekeete-sence, Validation française du questionnaire de coping « way of coping check-list-revisited » (WCCR) et analyse des événements stressants du quotidien » j, J Thérapie Comport Cogn, vol.8, issue.3, pp.100-112, 1998.

C. R. Brewin and E. A. Holmes, Psychological theories of posttraumatic stress disorder, Clin Psychol Rev. mai, vol.23, issue.3, pp.339-76, 2003.

L. R. Folkman and S. , Stress, appraisal and coping, 1984.

M. Zeidner, Handbook of Coping: Theory, Research, Applications, pp.452-484, 1996.

O. Hazanov-boskovitz,

, Université de Genève, faculté de psychologie et des sciences de l'éducations, 2003.

L. R. Folkman and S. , Stress, appraisal and coping, 1984.

M. Howlett, K. Doody, and J. Murray, Burnout in emergency department healthcare professionals is associated with coping style: a cross-sectional survey, Emerg Med J EMJ. sept, vol.32, issue.9, pp.722-729, 2015.

J. S. Beck, Cognitive therapy of poersonnality disorders. Frontiers of cognitive therapy

A. T. Beck, A. J. Rush, and B. Shaw, Cognitive therapy of depression, 1979.

R. M. Post, Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena, Neurosci Biobehav Rev, vol.31, issue.6, pp.858-73, 2007.

E. Kraepelin, Ziele und wege der psychiatrischen forschung, 1919.

G. L. Klerman, The spectrum of mania, Compr Psychiatry, vol.22, issue.1, pp.11-20, 1981.

H. S. Akiskal and O. Pinto, The evolving bipolar spectrum. Prototypes I, II, III, and IV, Psychiatr Clin North Am, vol.22, issue.3, pp.517-551, 1999.

C. Trichard, J. L. Martinot, and M. Alagille, Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal neuropsychological study chol Med, 1995.

P. Weiland-fiedler, K. Erickson, T. Waldeck, D. A. Luckenbaugh, D. Pike et al., Evidence for continuing neuropsychological impairments in depression, J Affect Disord, vol.82, issue.2, pp.253-261, 2004.

L. Clark, A. Sarna, and G. M. Goodwin, Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression, Am J Psychiatry, vol.162, issue.10, pp.1980-1982, 2005.

P. Fossati, F. Coyette, and A. Ergis, Influence of age and executive functioning on verbal memory of inpatients with depression, J Affect Disord. avr, vol.68, issue.2-3, pp.261-71, 2002.

J. Markela-lerenc, S. Kaiser, P. Fiedler, M. Weisbrod, and C. Mundt, Stroop performance in depressive patients: a preliminary report, J Affect Disord. août, vol.94, issue.1-3, pp.261-268, 2006.

R. J. Porter, P. Gallagher, J. M. Thompson, and A. H. Young, Neurocognitive impairment in drugfree patients with major depressive disorder, Br J Psychiatry J Ment Sci. mars, vol.182, pp.214-234, 2003.

M. P. Austin, P. Mitchell, and G. M. Goodwin, Cognitive deficits in depression: possible implications for functional neuropathology, Br J Psychiatry J Ment Sci. mars, vol.178, pp.200-206, 2001.

B. Ravnkilde, P. Videbech, K. Clemmensen, A. Egander, N. A. Rasmussen et al., Cognitive deficits in major depression, Scand J Psychol. juill, vol.43, issue.3, pp.239-51, 2002.

C. T. Gualtieri, L. G. Johnson, and K. B. Benedict, Neurocognition in depression: patients on and off medication versus healthy comparison subjects, J Neuropsychiatry Clin Neurosci, vol.18, issue.2, pp.217-242, 2006.

R. Elliott, R. Zahn, and J. Deakin, affective cognition and its disruption in mood disorders, Neuropsychopharmacology, vol.36, issue.1, pp.153-182, 2011.

J. Moll, R. De-oliveira-souza, and G. J. Garrido, The self as a moral agent: linking the neural bases of social agency and moral sensitivity, Soc Neurosci, vol.2, issue.3-4, pp.336-52, 2007.

M. M. Kurtz and R. T. Gerraty, A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state, Neuropsychology. sept, vol.23, issue.5, pp.551-62, 2009.

L. Iversen, S. D. Goodwin, and G. M. , Sustained attention deficit in bipolar disorder, Brain J of Psychiatry, vol.180, pp.313-319, 2002.

A. Martínez-arán, E. Vieta, and M. Reinares, Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder, Am J Psychiatry. févr, vol.161, issue.2, pp.262-70, 2004.

L. J. Robinson, Ferrier Evolution of cognitive impairment in bipolar disorder: a systematic rereview of cross ectional evidence, Bipolar Disord, vol.8, pp.103-119, 2006.

E. Bora, M. Yucel, and C. Pantelis, Cognitive impairment in affective psychose: a meta analysis, Schizophr Bull, vol.36, issue.1, pp.112-137, 2010.

E. Bora, M. Yucel, and C. Pantelis, Meta-analytic review of neurocognition in bipolar II disorder, Acta Psychiatr Scand, vol.123, pp.165-174, 2011.

C. Torrent, A. Martinez-aran, and C. Daban, Cognitive impairment in bipolar II disorder

, Brain J Psychiatry, vol.189, pp.254-263

P. Fossati, P. O. Harvey, L. Bastard, and G. , Memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression, Journal of Psychiatry Research, vol.38, issue.2, pp.137-144, 2004.

N. Correard, J. M. Azorin, and R. Belzeaux, Neurocognitive fuctioning in pure mania and mixed mania] encephale, vol.39, pp.157-61, 2013.

G. S. Malhi, B. Ivanovski, and D. Hadzi-pavlovic, Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia, Bipolar Disord, vol.9, issue.1-2, pp.114-139, 2007.

R. Motjabai, E. J. Bromet, and H. E. , Neuropsychological differences between first admission schizophrenia and psychotic affective disorder, Am J Psychiatry, vol.157, pp.1453-1460, 2000.

J. A. Sweeney, J. A. Kmiec, and D. J. Kupfer, Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery, Biological Psychiatry, vol.48, pp.674-685, 2000.

C. E. Bearden, Patterns of memory impairment in bipolar disorders and unipolar major depression. Psychiatry Research, vol.142, pp.139-150, 2005.

A. Borkowska and J. K. Rybakowski, Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar, Bipolar Disord, vol.3, issue.2, pp.88-94, 2001.

A. J. Thomas, P. Gallagher, L. J. Robinson, R. J. Porter, A. H. Young et al., A comparison of neurocognitive impairment in younger and older adults with major depression, Psychol Med. mai, vol.39, issue.5, pp.725-758, 2009.

I. N. Ferrier, R. Chowdhury, and J. M. Thompson, Neurocognitive function in unaffected first degree relatives of patients with bipolar disorder: a preliminary report, Bipolar Disord, vol.6, pp.319-323, 2004.

B. Arts, N. Jabben, L. Krabbendam, V. Os, and J. , Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives, Psychol Med, vol.38, issue.6, pp.771-785, 2008.

P. Martinot and M. L. , Recherche en neuroimagerie et adolescence. Rev Adolesc, 2009.

V. Lorenzetti, N. B. Allen, and A. Fornito, Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies, J Affect Disord. sept, vol.117, issue.1-2, pp.1-17, 2009.

S. M. Strakowski, C. M. Adler, and M. P. Delbello, Volumetric MRI studies of mood disorders : do they distinguish unipolar and bipolar disorder ?, Bipolar Disord, vol.4, issue.2, pp.80-88, 2002.

K. N. Botteron, M. Raichle, and W. C. Drevets, Volumetric reduction in left subgenual prefrontal cortex in early onset depression, Biol Psychiatry, vol.51, issue.4, pp.342-346, 2002.

M. Santos, L. S. Bezerra, A. Carvalho, and A. M. Brainer-lima, Global hippocampal atrophy in major depressive disorder: a meta-analysis of magnetic resonance imaging studies, Trends Psychiatry Psychother. déc, vol.40, issue.4, pp.369-78, 2018.

M. Master, F. P. Kusumakar, and V. , Hippocampal volume in early onset depression, BMC Med, vol.2, issue.2, 2004.

T. Frodl, E. M. Meisenzahl, and T. Zetzsche, Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects, Biol. Psychiatry, vol.53, pp.338-344, 2003.

R. S. Hastings, R. V. Parsey, M. A. Oquendo, V. Arango, and J. Mann, Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression, Neuropsychopharmacology, vol.29, pp.952-959338, 2004.

D. Ongur, W. C. Drevets, and J. L. Price, Glial reduction in the subgenual prefrontal cortex in mood disorders, Proc Natl Acad Sci, vol.95, pp.13290-13295, 1998.

G. Rajkowska, Cell pathology in bipolar disorder, Bipolar Disord, vol.7, issue.4, pp.105-116, 2002.

I. K. Lyoo, Y. H. Sung, and S. R. Dager, Regional cerebral cortical thinning in bipolar disorder, Bipolar Disord, vol.8, issue.1, pp.65-74, 2006.

T. Hajek, J. Cullis, and T. Novak, Brain structural signature of familial predispo-sition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gy-rus, Biol Psychiatry, vol.73, issue.2, pp.144-152, 2013.

K. Matsuo, M. Kopecek, and M. A. Nicoletti, New structural brain imaging endophenotype in bipolar disorder, Mol Psychiatry, vol.17, pp.412-420, 2012.

W. C. Drevets, J. L. Price, and J. R. Simpson, Subgenual prefrontal cortex abnormalities in mood disorders, Nature, vol.386, issue.6627, pp.824-831, 1997.

H. P. Blumberg, J. H. Krystal, and R. Bansal, Rapid-Cycling, and Pharmacotherapy Effects on Ventral Prefrontal Cortex in Bipolar Disorder: A Cross-Sectional Study, Biol Psychiatry, vol.59, issue.7, pp.611-619, 2006.

P. Harrison, The neuropathology of primary mood disorder, Brain, vol.125, pp.1428-1477, 2002.

P. Brambilla, K. Harenski, M. Nicoletti, R. B. Sassi, A. G. Mallinger et al., MRI investigation of temporal lobe structures in bi-polar patients, J Psychiatr Res, vol.37, pp.287-95, 2003.

C. Wijeratne and W. Sachdev-s-wen, Hippocampal and amygdala volumes in an older bipolar disorder sample, Int Psychogeriatr, vol.25, issue.1, pp.54-60, 2013.

L. L. Altshuler, G. Bartzokis, and T. Grieder, Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia : an MRI study demonstrating neuroanatomic specificity, Arch Gen Psychiatry, vol.55, issue.7, pp.663-667, 1998.

E. Bora, M. Yucel, and C. Pantelis, Cognitive impairment in schizophrenia and affective psy-choses: implications for DSM-V criteria and beyond, Schizophr. Bull, vol.36, issue.1, pp.36-42, 2010.

S. M. Strakowski, M. P. Delbello, and K. W. Sax, Brain magnetic resonance imaging of structural abnormalities in bipolar disorder, Arch Gen Psychiatry, vol.56, issue.3, pp.254-60, 1999.

C. M. Adler, A. D. Levine, and M. P. Delbello, Changes in gray matter volume in patients with bipolar disorder, Biol. Psychiatry, vol.58, issue.2, pp.151-157, 2005.

G. Malhi, B. Ivanovski, and D. Hadzi-pavlovic, Neuropsychological deficits and func-tional impairment in bipolar depression, hypomania and euthymia, Bipolar Disorders, vol.9, issue.1-2, pp.114-139, 2007.

P. Hauser, J. Matochik, and L. L. Altshuler, MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders, J Affect Disord, vol.60, pp.25-32, 2000.

R. M. Dupont, T. L. Jernigan, and J. C. Gillin, Subcortical signal hyperintensities in bipolar patients detected by MRI, Psychiatry Res, vol.21, pp.357-358, 1987.

G. S. Figiel, K. Knishnan, and V. P. Rao, Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects, J Neuropsychiatry Chin Neurosci, vol.3, pp.18-22, 1991.

W. M. Mcdonald, K. Knishnan, and P. M. Doraiswamy, Occurrence of subcortical hyperintensities in elderly subjects with mania, Psychiatry Res: Neuroimaging, vol.40, pp.211-220, 1991.

L. L. Altshuler, J. G. Curran, P. Houser, J. Mintz, K. Denikoff et al., T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis, Am J Psychiatry, vol.152, pp.1139-1183, 1995.

E. H. Aylward, J. V. Roberts-twillie, and P. E. Barta, Basal Ganglia Volumes and White Matter Hyperintensities in Patients With Bipolar Disorder, Am J, vol.151, issue.3, pp.687-93, 1994.

H. Elkis, L. Friedman, and A. Wise,

, Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders, Arch Gen Psychiatry, vol.52, pp.735-781, 1995.

S. M. Strakowski, M. P. Delbello, and C. Adler, Neuroimaging in bipolar disorder, Bipolar Disord, vol.2, issue.3, pp.148-64, 2000.

T. Fujikawa, S. Yamawaki, and Y. Touhouda, Silent cerebral infarctions in patients with lateonset mania, Stroke, vol.26, issue.6, pp.946-949, 1995.

P. Rabins, E. Aylward, S. Holyrod, and G. Pearlson, MRI findings differentiate between late-onset schizophrenia and late-life mood disorder, International Journal of Geriatric Psychiatry, vol.15, issue.10, pp.954-960, 2000.

J. L. Beyer, R. Young, and M. Kuchibhatla, Hyperintense MRI lesions in bipolar disorder: A metaanalysis and review, Int Rev Psychiatry, vol.21, issue.4, pp.394-409, 2009.

M. E. Lisy, K. B. Jarvis, and M. P. Delbello, Progressive neurostructural changes in adolescent and adult patients with bipolar disorder, Bipolar Disord, vol.13, issue.4, pp.396-405, 2011.

J. E. Sussmann, . Lymer, . Gks, and J. Mckirdy, White matter abnor-malities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic reso-nance imaging, Bipolar Disorders, vol.11, issue.1, pp.11-18, 2009.

J. Houenou, M. Wessa, and G. Douaud, Increased white matter connectivity in euthymic bipolar patients : diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex, Mol. Psychiatry, vol.12, pp.1001-1010, 2007.

S. D. Bruno, G. J. Barker, and M. Cercignani, A study of bipolar disorder using magnetization transfer imaging and voxelbased morphometry, Brain, vol.127, pp.2433-2473, 2004.

F. Benedetti, M. Absinta, and M. A. Rocca, Tract-specific white matter structural disruption in patients with bipolar disorder, Bipolar Disord, vol.13, issue.4, pp.414-424, 2011.

P. Brambilla and M. Bellani, Yeh PH> Myelination in bipolar patients and the effects of mood stabilizers on brain anatomy, Curr Pharm Des, vol.15, issue.22, pp.2632-2638, 2009.

P. Fusar-poli, O. Howes, and A. Bechdolf, Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies, J Psychiatry Neurosci, vol.37, issue.3, pp.170-84, 2012.

K. R. Krishnan, W. M. Mcdonald, and P. M. Doraiswamy, Neuroanatomical substrates of depression in the elderly, Eur Arch Psychiatry Clin Neurosci, vol.243, pp.41-46, 1993.

I. A. Parashos, L. A. Tupler, T. Blitchington, and K. R. Krishnan, Magnetic-resonance morphometry in patients with major depression, Psychiatry Res, vol.84, pp.7-15, 1998.

B. Lrjr, J. M. Schwartz, and M. E. Phelps, Reduction of prefrontal cortex glucose metabolism common to three types of depression Arch Gen Psychiatry, vol.46, pp.243-50, 1989.

W. C. Drevets, J. L. Price, and J. R. Simpson, Subgenual prefrontal cortex abnormalities in mood disorders, Nature, vol.386, issue.6627, pp.824-831, 1997.

P. B. Fitzgerald, T. J. Oxley, and A. R. Laird, An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression, Pchiatry Res, vol.148, issue.1, pp.33-45, 2006.

J. Du, E. T. Rolls, and W. Cheng, Functional connectivity of the orbitofrontal cortex, anterior cingulate cortex, and inferior frontal gyrus in humans, vol.123, pp.185-199, 2020.

L. Ct, T. P. Su, and S. J. Wang, Prefrontal glucose metabolism in medication resistant major depression, Br J Psychiatry, vol.206, issue.4, pp.316-339, 2015.

V. Navarro, C. Gastro, and F. Lomena, Frontal Cerebral Perfusion After Antidepressant Drug Treatment Versus ECT in Elderly Patients With Major Depression: A 12-month Follow-Up Control Study, J Clin Psychiatry, vol.65, issue.5, pp.656-61, 2004.

C. L. Fales, D. M. Barch, and M. M. Rundle, Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression, Biol Psychiatry, vol.63, issue.4, pp.377-84, 2008.

S. C. Matthews, . Strigo, . Ia, and A. N. Simmons, Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder, Journal of Affective Disorders, vol.111, pp.13-20, 2008.

W. Cheng and E. T. Rolls, Qiu J Functional connectivity of the human amygdala in health and in depression, Social Cog and Aff Neuro, pp.557-568, 2018.

R. A. O'connell, R. L. Van-heertum, and D. Luck, Single-photon Emission Computed Tomography of the Brain in Acute Mania and Schizophrenia, J Neuroimaging, vol.5, issue.2, pp.101-105, 1995.

C. H. Chen, J. Suckling, B. R. Lennox, C. Ooi, and E. T. Bullmore, A quantitative metaanalysis of fMRI studies in bipolar disorder, Bipolar Disord, vol.13, issue.1, pp.1-15, 2011.

J. S. Rubinsztein, P. C. Fletcher, and R. D. Rogers, Decision marking in mania : a PET study, Brain, vol.124, pp.2550-63, 2001.

M. Schecklmann, T. Dresler, and S. Beck, Reduced Prefrontal Oxygenation During Object and Spatial Visual Working Memory in Unipolar and Bipolar Depression, Psychiatry Res, vol.194, issue.3, pp.378-384, 2011.

H. P. Blumber, H. C. Leung, and . Skudlarskip, A functional magnetic resonance imaging study of bipolar disorder: state and trait related dysfunction in ventral prefrontal cortices, Arch Gen Psychiatriy, vol.60, pp.601-609, 2003.

H. Blumber, A. Martin, and J. Kauffman, Fronto striatal abnormalities in adolescents with bipolar disorder : preliminary observation from functional MRI, Am J Psychiatriy, vol.160, pp.1345-1347, 2005.

J. Towsend and S. Y. Bookheimer, Foland-Ross LC> fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects, Psychiatry Res, vol.182, issue.1, pp.22-31, 2010.

Y. Grube and S. A. Kanayama, fMRI during affect discrimination in bipolar affective disorder, Bipolar Disord, vol.2, issue.3, pp.237-285, 2000.

W. R. Marchand and D. Yurgelun-todd, Striatal structure and function in mood disorders: a comprehensive review, Bipolar Disord, vol.12, issue.8, pp.764-85, 2010.

M. L. Phillips, C. D. Ladouceur, and W. C. Drevets, A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder, Mol Psychiatry, vol.13, issue.9, pp.829-57, 2008.

J. Houenou, J. Frommberger, and S. Carde, Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses

M. Aan-het-rot, S. J. Mathew, and D. S. Charney, Neurobiological mechanisms in major depressive disorder, CMAJ Can Med Assoc J J Assoc Medicale Can. 3 févr, vol.180, issue.3, pp.305-318, 2009.

. M. Stahl-s, Medecine Sciences, traduction de la 4ème édition américaine, Bases neuroscientifiques et applications pratiques, 2015.

D. Purves, F. M. Traduit-coquery, P. Gailly, N. Tajeddine, . Neurosciences et al., , p.6, 2019.

, Fundamentals of neurobiology | Lundbeck Institute Campus

D. Sur,

J. Hannon and D. Hoyer, Molecular biology of 5-HT receptors, Behav Brain Res. 16 déc, vol.195, issue.1, pp.198-213, 2008.

D. Hoyer, J. P. Hannon, and G. R. Martin, Molecular, pharmacological and functional diversity of 5-HT receptors, Pharmacol Biochem Behav. avr, vol.71, issue.4, pp.533-54, 2002.

S. Kapur and R. G. , Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia, Annu Rev Med, vol.52, pp.503-520, 2001.

D. S. Charney, D. B. Menkes, and G. R. Heninger, Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry, vol.38, pp.1160-80, 1981.

R. S. Duman, G. R. Heninger, and E. J. Nestler, A molecular and cellular theory of depression, Arch Gen Psychiatry. juill, vol.54, issue.7, pp.597-606, 1997.

K. Gajcy, S. Lochy?ski, and T. Librowski, A role of GABA analogues in the treatment of neurological diseases, Curr Med Chem, vol.17, issue.22, pp.2338-2385, 2010.

S. J. Yoon, I. K. Lyoo, C. Haws, T. Kim, B. M. Cohen et al., Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. juin, vol.34, issue.7, pp.1810-1818, 2009.

J. H. Krystal, G. Sanacora, H. Blumberg, A. Anand, D. S. Charney et al., Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments, Mol Psychiatry, vol.7, issue.1, pp.71-80, 2002.

J. B. Monahan, V. M. Corpus, W. F. Hood, J. W. Thomas, and R. P. Compton, Characterization of a [3H]glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex, J Neurochem. août, vol.53, issue.2, pp.370-375, 1989.

R. M. Berman, A. Cappiello, A. Anand, D. A. Oren, G. R. Heninger et al., Antidepressant effects of ketamine in depressed patients, Biol Psychiatry. 15 févr, vol.47, issue.4, pp.351-355, 2000.

J. D. Parkes, K. J. Zilkha, P. Marsden, R. C. Baxter, and K. Rp, Amantadine dosage in treatment of Parkinson's disease, Lancet Lond Engl. 30 mai, vol.1, issue.7657, pp.1130-1133, 1970.

L. Bode, D. E. Dietrich, R. Stoyloff, H. M. Emrich, and H. Ludwig, Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression, Lancet Lond Engl. 18 janv, vol.349, issue.9046, pp.178-187, 1997.

J. Kornhuber, G. Quack, W. Danysz, K. Jellinger, W. Danielczyk et al., Therapeutic brain concentration of the NMDA receptor antagonist amantadine, Neuropharmacology. juill, vol.34, issue.7, pp.713-734, 1995.

M. Rizzo and P. L. Morselli, Amantadine-induced aggressiveness, Br Med J. 1 juill, vol.3, issue.5817, p.50, 1972.

Y. Godin, L. Heiner, J. Mark, and P. Mandel, Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism, J Neurochem. juin, vol.16, issue.3, pp.869-73, 1969.

M. C. Sawaya, R. W. Horton, and B. S. Meldrum, Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA. Epilepsia, vol.16, pp.649-55, 1975.

A. C. Swann, F. Petty, C. L. Bowden, S. C. Dilsaver, J. R. Calabrese et al., Mania: gender, transmitter function, and response to treatment. Psychiatry Res, vol.88, pp.55-61, 1999.

D. E. Casey, D. G. Daniel, A. A. Wassef, K. A. Tracy, P. Wozniak et al., Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. janv, vol.28, issue.1, pp.182-92, 2003.

W. H. Berrettini, J. I. Nurnberger, T. A. Hare, S. Simmons-alling, G. E. Post et al., Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate, Biol Psychiatry. févr, vol.18, issue.2, pp.185-94, 1983.

B. Lee and Y. Kim, The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment, Psychiatry Investig. déc, vol.7, issue.4, pp.231-236, 2010.

B. Lu, P. T. Pang, and N. H. Woo, The yin and yang of neurotrophin action, Nat Rev Neurosci. août, vol.6, issue.8, pp.603-617, 2005.

N. M. Tsankova, O. Berton, W. Renthal, A. Kumar, R. L. Neve et al., Sustained hippo-campal chromatin regulation in a mouse model of depression and antidepressant action, Nat. Neurosci, vol.9, issue.4, pp.519-525, 2006.

C. Ernst, V. Deleva, X. Deng, A. Sequeira, A. Pomarenski et al., Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers, Arch Gen Psychiatry. janv, vol.66, issue.1, pp.22-32, 2009.

B. Mellstrom, B. Torres, W. A. Link, and J. R. Naranjo, The BDNF gene: exemplifying complexity in Ca2+ -dependent gene expression, Crit Rev Neurobiol, vol.16, issue.1-2, pp.43-52, 2004.

B. Mellström and J. R. Naranjo, Mechanisms of Ca(2+)-dependent transcription, Curr Opin Neurobiol. juin, vol.11, issue.3, pp.312-321, 2001.

F. D. Miller and D. R. Kaplan, Neurotrophin signalling pathways regulating neuronal apoptosis, Cell Mol Life Sci CMLS. juill, vol.58, issue.8, pp.1045-53, 2001.

M. Sandler, Neurotrophins: possible role in affective disorders, Hum Psychopharmacol. janv, vol.16, issue.1, pp.61-65, 2001.

B. Lee and Y. Kim, The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment, Psychiatry Investig. déc, vol.7, issue.4, pp.231-236, 2010.

A. M. Rasmusson, L. Shi, and R. Duman, Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock

Y. Dwivedi, H. S. Rizavi, R. R. Conley, R. C. Roberts, C. A. Tamminga et al., Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects, Arch Gen Psychiatry. août, vol.60, issue.8, pp.804-819, 2003.

G. N. Pandey, X. Ren, H. S. Rizavi, R. R. Conley, R. C. Roberts et al., Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims, Int J Neuropsychopharmacol. déc, vol.11, issue.8, pp.1047-61, 2008.

F. Matrisciano, S. Bonaccorso, and A. Ricciardi, Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine, J Psychiatr Res. janv, vol.43, issue.3, pp.247-54, 2009.

H. Manji and . Depression, III: treatments, Am J Psychiatry, vol.160, issue.1, p.24, 2003.

. David, Neurogenesisdependent and -independent effects of fluoxetine in an animal model of anxiety/depression, Neuron, vol.62, issue.4, pp.479-93, 2009.

R. S. Duman and D. S. Charney, Cell atrophy and loss in major depression, Biol Psychiatry, vol.45, pp.1083-1087, 1999.

R. S. Duman, J. Malberg, and J. Thome, Neuralplasticity to stress and anti-depressant treatment, Biol Psychiatry, vol.46, pp.1181-91, 1999.

A. O. Aydemir, O. E. Deveci, and F. Taskin, Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, vol.31, issue.5, pp.1023-1026, 2007.

B. H. Lee, H. Kim, S. H. Park, and Y. K. Kim, Decreased plasma BDNF level in depressive patients, J. Affect. Disord, vol.101, issue.1-3, pp.239-244, 2007.

B. H. Lee and Y. K. Kim, The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment, Psychiatry Investigation, vol.7, issue.4, pp.231-235, 2010.

R. Banerjee, A. K. Ghosh, B. Ghosh, S. Bhattacharyya, and A. C. , Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: an analysis in human postmortem brain, Clin. Med. Insights Pathol, vol.6, pp.1-11, 2013.

W. Hong, J. Fan, C. Yuan, C. Zhang, Y. Hu et al., Significantlydecreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depression, Neuroreport, 2014.

X. Shen, M. Qian, Y. Yuan, J. Sun, H. Zhong et al., Research on association of BDNF gene Val66Met polymorphism with efficacy of antidepressants and plasma BDNF level, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, vol.31, issue.2, pp.196-200, 2014.

F. Duclot and M. Kabbaj, Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants, J. Exp. Biol, vol.218, issue.1, pp.21-31, 2015.

R. Ghosh, R. Gupta, M. S. Bhatia, A. K. Tripathi, and L. K. Gupta, Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine, Asian J. Psychiatry, vol.18, pp.37-41, 2016.

R. Gupta, K. Gupta, A. K. Tripathi, M. S. Bhatia, and L. K. Gupta, Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-a in patients of major depressive disorder with severe depression, Pharmacology, vol.97, issue.3-4, pp.184-188, 2016.

M. M. , ): ): ): ): ): ): ): ): ), vol.16, p.61, 2001.

B. Lee and Y. Kim, The Roles of BDNF in

C. Aston, L. Jiang, and B. P. Sokolov, Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder, Mol. Psychiatry, vol.10, issue.3, pp.309-322, 2005.

W. M. Tian, J. Zhang, K. Zhang, H. Yang, Y. Sun et al., A study of the functional significance of epidermal growth factor in major depressivedisorder, Psychiatr. Genet, vol.22, issue.4, pp.161-167, 2012.

E. Milanesi, A. Minelli, N. Cattane, A. Cattaneo, C. Mora et al., ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder, BMC Psychiatry, vol.12, p.145, 2012.

Y. Xiong, J. Zeng, D. H. Wan, D. Xiaohan, J. Tan et al., The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia, Psychiatry Res, vol.189, issue.1, pp.72-76, 2011.

B. S. Diniz, A. L. Teixeira, R. Machado-vieira, L. L. Talib, W. F. Gattaz et al., Reduced serum nerve growth factor in patients with late-Life depression, Am. J. Geriatr. Psychiatry, vol.21, issue.5, pp.493-496, 2013.

M. Martino, G. Rocchi, A. Escelsior, P. Contini, S. Colicchio et al., NGF serum levels variations in major depressed patients receiving duloxetine, Psychoneuroendocrinology, vol.38, issue.9, pp.1824-1828, 2013.

C. D. Wiener, S. Ferrica-de-mello, F. Moreira, G. Bittencourt, J. F. De-oliveira et al., Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk, J. Affect. Disord, vol.184, pp.245-248, 2015.

C. A. Turner, E. L. Gula, and L. P. Taylor, Set al, Antidepressant-like effects of intracerebroventricular FGF2 in rats, Brain Res, vol.1224, pp.63-68, 2008.

M. Mitschelen, H. Yan, and J. A. Farley, Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression, Neuroscience, vol.185, pp.50-60, 2011.

C. A. Turner, R. C. Thompson, and W. E. Bunney, Altered choroid plexus gene expression in major depressive disorder, Front. Hum. Neurosci, vol.8, p.238, 2014.

F. Lin, J. Suhr, S. Diebold, and K. L. Heffner, Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults, Psychoneuroendocrinology, vol.42, pp.118-123, 2014.

Y. Cheng, R. M. Rodriguiz, and S. R. Murthy, Neurotrophic Factor-a1 prevents stressinduced depression through enhancement of neurogenesis and is activated by rosiglitazone, Mol. Psychiatry, vol.20, issue.6, pp.744-754, 2015.

J. Isung, S. Aeinehband, F. Mobarrez, and B. , Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters, Transl. Psychiatry, vol.2, p.196, 2012.

Z. Kotan, E. Sarandol, E. Kirhan, G. Ozkaya, and S. Kirli, Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features, Ther. Adv. Psychopharmacol, vol.2, issue.2, pp.65-74, 2012.

D. Berent, M. Macander, and J. Szemraj, Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins, Acta Neurobiol. Exp. (Wars), vol.74, issue.1, pp.82-90, 2014.

R. Musil, M. J. Schwarz, and M. Riedel, Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression-no influence of celecoxib treatment, J. Affect. Disord, vol.134, issue.1-3, pp.217-225, 2011.

L. Sutcigil, C. Oktenli, and U. Musabak, Pro-and anti-Inflammatory cytokine balance in major depression: effect of sertraline therapy, Clin. Dev. Immunol, p.76396, 2007.

M. Choi and H. Son, Effects of serotonin on erythropoietin expression in mouse hippocampus, Exp. Neurobiol, vol.22, issue.1, pp.45-50, 2013.

K. W. Miskowiak, M. Vinberg, and L. Glerup, Neural correlates of improved executive function following erythropoietin treatment in mood disorders, Psychol. Med, pp.1-13, 2016.

B. S. Fernandes, C. S. Gama, and K. M. Cereser, Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and metaregression analysis, J. Psychiatr. Res, vol.45, issue.8, pp.995-1004, 2011.

B. S. Fernandes, C. S. Gama, and K. M. Cereser, Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and metaregression analysis, J. Psychiatr. Res, vol.45, issue.8, pp.995-1004, 2011.

M. A. Rabie, M. Mohsen, and M. Ibrahim, Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder, J. Affect. Disord, vol.162, pp.67-72, 2014.

A. Piccinni, A. Veltri, and D. Costanzo, Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder, J. Affect. Disord, vol.171, pp.167-170, 2015.

X. Liu, T. Zhang, S. He, and B. Hong, Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder, Psychiatry Res, 2014.

A. Piccinni, A. Veltri, and D. Costanzo, Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder, J. Affect. Disord, vol.171, pp.167-170, 2015.

K. Munkholm, M. Vinberg, and L. V. Kessing, Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis, Mol. Psychiatry, vol.21, issue.2, pp.216-228, 2016.

A. B. Cunha, B. N. Frey, and A. C. Andreazza, Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes, Neurosci. Lett, vol.398, issue.3, pp.215-219, 2006.

M. Berk, Neuroprogression: pathways to progressive brain changes in bipolar disorder, International Journal of Neuropsychopharmacology, vol.12, issue.4, pp.441-445, 2009.

M. Berk, P. Conus, and F. Kapczinski, From neuroprogression to neuroprotection: impli-cations for clinical care, Medical Journal of Australia, vol.193, issue.4, pp.36-40, 2010.

M. Berk, F. Kapczinski, and A. C. Andreazza, Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors, Neurosci. Biobehav. Rev, vol.35, issue.3, pp.804-817, 2011.

H. Yamamori, T. Ishima, and Y. Yasuda, Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population, Neurosci. Lett, vol.612, pp.167-171, 2016.

. G. =j, A. R. Fiedorowicz, C. P. Prossin, and . Johnson, Peripheral inflammation during abnormal mood states in bipolar I disorder, J. Affect. Disord, vol.187, pp.172-178, 2015.

K. Tu, M. Wu, and Y. Chen, Significantly higher peripheral insulin-like growth factor-1 levels in patients with major depressive disorder or bipolar disorder than in healthy controls: a meta-analysis and review under guideline of PRISMA, Medicine, vol.95, issue.4, p.2411, 2016.

, Masson et Cie,libraires de l'Académie de médecine, Les Facteurs endocriniens du caractère, 1926.

H. Selye, A syndrome produced by diverse nocuous agents, J Neuropsychiatry Clin Neurosci, vol.10, issue.2, pp.230-231, 1936.

C. B. Nemeroff, E. Widerlöv, G. Bissette, H. Walléus, I. Karlsson et al., Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients, Science. 14 déc, vol.226, issue.4680, pp.1342-1346, 1984.

F. C. Raadsheer, W. J. Hoogendijk, F. C. Stam, F. J. Tilders, and D. F. Swaab, Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients, Neuroendocrinology. oct, vol.60, issue.4, pp.436-480, 1994.

G. Bissette, V. Klimek, J. Pan, C. Stockmeier, and G. Ordway, Elevated concentrations of CRF in the locus coeruleus of depressed subjects, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. juill, vol.28, issue.7, pp.1328-1363, 2003.

R. T. Rubin, R. E. Poland, I. M. Lesser, R. A. Winston, and A. L. Blodgett, Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls, Arch Gen Psychiatry. avr, vol.44, issue.4, pp.328-364, 1987.

J. S. Purba, W. J. Hoogendijk, M. A. Hofman, and D. F. Swaab, Increased number of vasopressin-and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression, Arch Gen Psychiatry. févr, vol.53, issue.2, pp.137-180, 1996.

B. J. Carroll, G. C. Curtis, and J. Mendels, Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients, Arch Gen Psychiatry. sept, vol.33, issue.9, pp.1051-1059, 1976.

B. J. Carroll, M. Feinberg, and J. F. Greden, A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility, Arch Gen Psychiatry. janv, vol.38, issue.1, pp.15-22, 1981.

S. Holsboer, O. A. Muller, and H. G. Doerr, ACTH and multisteroid responses to corticotropinreleasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression, Psychoneuroendocrinology, vol.9, issue.2, pp.147-60, 1984.

H. Kunugi, T. Urushibara, and S. Nanko, Combined DEX/CRH test among Japanese patients with major depression, J Psychiatr Res. avr, vol.38, issue.2, pp.123-131, 2004.

S. Watson, P. Gallagher, and M. S. Smith, The dex/CRH test--is it better than the DST?, Psychoneuroendocrinology. août, vol.31, issue.7, pp.889-94, 2006.

I. Heuser, . Yassouridis, and . Holsboer, The Combined dexamethasone/CRH Test: A Refined Laboratory Test for Psychiatric Disorders

C. M. Pariante, A. S. Papadopoulos, and L. Poon, A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis, Biol Psychiatry. 1 juin, vol.51, issue.11, pp.922-952, 2002.

M. F. Juruena, C. M. Pariante, and A. S. Papadopoulos, Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance

, Br J Psychiatry J Ment Sci. avr, vol.194, issue.4, pp.342-351, 2009.

C. Stetler and G. E. Miller, Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research, Psychosom Med. mars, vol.73, issue.2, pp.114-140, 2011.

S. Watson, P. Gallagher, J. C. Ritchie, I. N. Ferrier, and A. H. Young, Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder, Br J Psychiatry J Ment Sci. juin, vol.184, pp.496-502, 2004.

C. Heim and C. B. Nemeroff, The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies, Biol Psychiatry. 15 juin, vol.49, issue.12, pp.1023-1062, 2001.

P. D. Butler, J. M. Weiss, J. C. Stout, and C. B. Nemeroff, Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus, J Neurosci Off J Soc Neurosci. janv, vol.10, issue.1, pp.176-83, 1990.

C. D. Conrad, Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis, Rev Neurosci, vol.19, issue.6, pp.395-411, 2008.

R. M. Sapolsky, L. C. Krey, and B. S. Mcewen, The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis, Endocr Rev. août, vol.7, issue.3, pp.284-301, 1986.

B. S. Mcewen, Re-examination of the glucocorticoid hypothesis of stress and aging, Prog Brain Res, vol.93, pp.382-383, 1992.

B. S. Mcewen, J. M. Weiss, and L. S. Schwartz, Selective retention of corticosterone by limbic structures in rat brain, Nature, vol.220, issue.5170, pp.911-913, 1968.

B. S. Mcewen, J. M. Weiss, and L. S. Schwartz, Uptake of corticosterone by rat brain and its concentration by certain limbic structures, Brain Res, vol.16, issue.1, pp.227-268, 1969.

M. M. Sánchez, L. J. Young, P. M. Plotsky, and T. R. Insel, Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation, J Neurosci Off J Soc Neurosci. 15 juin, vol.20, issue.12, pp.4657-68, 2000.

J. D. Dunn and S. E. Orr, Differential plasma corticosterone responses to hippocampal stimulation, Exp Brain Res, vol.54, issue.1, pp.1-6, 1984.

R. M. Sapolsky, L. C. Krey, and B. S. Mcewen, Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging, J Neurosci Off J Soc Neurosci. mai, vol.5, issue.5, pp.1222-1229, 1985.

M. Joëls, H. Karst, and D. Alfarez, Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus, Stress Amst Neth. déc, vol.7, issue.4, pp.221-252, 2004.

K. Pham, J. Nacher, P. R. Hof, and B. S. Mcewen, Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus

, Eur J Neurosci. févr, vol.17, issue.4, pp.879-86, 2003.

H. Rosenbrock, E. Koros, and A. Bloching, Effect of chronic intermittent restraint stress on hippocampal expression of marker proteins for synaptic plasticity and progenitor cell proliferation in rats, Brain Res. 8 avr, vol.1040, issue.1-2, pp.55-63, 2005.

. Sunanda-null, M. S. Rao, and T. R. Raju, Effect of chronic restraint stress on dendritic spines and excrescences of hippocampal CA3 pyramidal neurons--a quantitative study, Brain Res, vol.694, issue.1-2, pp.312-319, 1995.

N. R. Nichols, M. Zieba, and N. Bye, Do glucocorticoids contribute to brain aging?, Brain Res Brain Res Rev, vol.37, issue.1-3, pp.273-86, 2001.

A. M. Magariños and B. S. Mcewen, Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors, Neuroscience. nov, vol.69, issue.1, pp.83-91, 1995.

E. Kitraki, O. Kremmyda, D. Youlatos, A. M. Kittas, and C. , Spatial performance and corticosteroid receptor status in the 21-day restraint stress paradigm, Ann N Y Acad Sci. juin, vol.1018, pp.323-330, 2004.

K. Nishimura, S. Makino, Y. Tanaka, T. Kaneda, and K. Hashimoto, Altered expression of p53 mRNA in the brain and pituitary during repeated immobilization stress: negative correlation with glucocorticoid receptor mRNA levels, J Neuroendocrinol. janv, vol.16, issue.1, pp.84-91, 2004.

R. M. Sapolsky, L. C. Krey, and B. S. Mcewen, Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response, Proc Natl Acad Sci, vol.81, pp.6174-6181, 1984.

C. D. Conrad, What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus?, Behav Cogn Neurosci Rev. mars, vol.5, issue.1, pp.41-60, 2006.

P. Robel and E. E. Baulieu, Neuro-steroids: 3,8-hydroxy-.6.5-derivatives in the rodent brain, Neurochem Int, vol.7, pp.953-961, 1985.

P. Robel, E. Bourreau, and C. Corpéchot, Neuro-steroids: 3,8-hydroxy-.6.5-derivatives in rat and monkey brain, J Steroid Bio chem, vol.27, pp.649-55, 1987.

E. E. Baulieu, Steroid hormones in the brain : several mechanisms ?, pp.3-14, 1981.

E. E. Baulieu, P. Robel, and O. Vatier, Neuro steroids: pregnenolone and dehydroepi androsterone in the brain, Receptor interactions, vol.48, pp.89-104, 1987.

A. Lanthier and V. V. Patwardhan, Sex steroids and 5-en-3/3-hydroxysteroids in specific regions of the human brain and cranial nerves, Steroid Biochem, vol.25, issue.1, pp.445-454, 1986.

C. Lacroix, J. Fiet, and J. P. Benais, Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 1 7-hydroxyprogesterone in specifie regions of human brain, Steroid Biochem, vol.28, issue.1, pp.317-342, 1987.

W. E. Stumpf and M. Sar, Steroid hormone target sites in the brain: the differential distribution of estrogen, progestin, androgen and glucocorticosteroid receptors, J Steroid Biochem, vol.7, pp.1163-70, 1976.

M. Pecins-thompson, N. A. Brown, and C. L. Bethea, Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques, Mol Brain Res, vol.53, pp.120-129, 1998.

D. R. Rubinow, P. J. Schmidt, and C. A. Roca, Estrogen-serotonin interactions: Implications for affective regulation, Biol Psychiatry, vol.44, pp.839-850, 1998.

B. Sumner and G. Fink, Estrogen increases the density of 5-Hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat, J Steroid Biochem Mol Biol, vol.54, pp.15-20, 1995.

M. Thomas, D. A. Bland, and C. H. Clarke, Estrogen regulation of serotonin (5-HT) transporter and 5-HT1A receptor mRNA in female rat brain, Abstr Soc Neurosci, vol.23, p.1501, 1997.

E. L. Moses, W. C. Drevets, G. Smith, C. A. Mathis, B. N. Kalro et al., Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: A PET study, Biol Psychiatry, vol.48, pp.854-860, 2000.

L. M. Shulman, Is there a connection between estrogen and Parkinson's disease?, Parkinsonism Relat Disord, vol.8, pp.289-295, 2002.

J. Kulkarni, C. Gurvich, and S. J. Lee, Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia, Psychoneuroendocrinology, vol.35, pp.1142-1147, 2010.

D. Paolo, T. Poyet, P. Labrie, and F. , Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats, Prog Neuropsychopharmacol Biol Psychiatry, vol.6, pp.377-382, 1982.

M. Morissette, D. Paolo, and T. , Sex and estrous cycle variations of rat striatal dopamine uptake sites, Neuroendocrinology, vol.58, pp.16-22, 1993.

J. B. Becker, Gender differences in dopaminergic function in striatum and nucleus accumbens, Pharmacol Biochem Behav, vol.64, pp.803-812, 1999.

D. Zhang, S. Yang, and C. Yang, Estrogen regulates responses of dopamine neurons in the ventral tegmental area to cocaine, Psychopharmacology (Berl), vol.199, pp.625-635, 2008.

M. Blum, B. S. Mcewen, and J. L. Roberts, Transcriptional analysis of tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic neurons of the rat arcuate nucleus after estrogen treatment, J Biol Chem, vol.262, pp.817-821, 1987.

C. Pasqualini, V. Leviel, and B. Guibert, Inhibitory actions of acute estradiol treatment on the activity and quantity of tyrosine hydroxylase in the median eminence of ovariectomized rats, J Neuroendocrinol, vol.3, pp.575-580, 1991.

J. Kulkarni, A. De-castella, and P. B. Fitzgerald, Estrogen in severe mental illness: A potential new treatment approach, Arch Gen Psychiatry, vol.65, pp.955-960, 2008.

A. M. Etgen, M. A. Ansonoff, and A. Quesada, Mechanisms of ovarian steroid regulation of norepinephrine receptor-mediated signal transduction in the hypothalamus: Implications for female reproductive physiology, Horm Behav, vol.40, pp.169-177, 2001.

G. B. Karkanias and A. M. Etgen, Estradiol attenuates ?2-adrenoceptor-mediated inhibition of hypothalamic norepinephrine release

N. Petitti and A. M. Etgen, Alpha 1-adrenoceptor augmentation of beta-stimulated cAMP formation is enhanced by estrogen and reduced by progesterone in rat hypothalamic slices, J Neurosci, vol.10, pp.2842-2849, 1990.

S. Ungar, M. H. Makman, S. A. Morris, and A. M. Etgen, Estrogen uncouples beta-adrenergic receptor from the stimulatory guanine nucleotide-binding protein in female rat hypothalamus, Endocrinology, vol.133, pp.2818-2826, 1993.

R. M. Shansky, G. Bender, and A. Arnsten, Estrogen prevents norepinephrine alpha-2a receptor reversal of stress-induced working memory impairment, Stress, vol.12, pp.457-463, 2009.

Á. Kiss, A. M. Delattre, and S. Pereira, 17?-Estradiol replacement in young, adult and middleaged female ovariectomized rats promotes improvement of spatial reference memory and an antidepressant effect and alters monoamines and BDNF levels in memory-and depression-related brain areas, Behav Brain Res, vol.227, pp.100-108, 2012.

F. Sohrabji, R. C. Miranda, and C. D. Toran-allerand, Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons, J Neurosci, vol.14, pp.459-471, 1994.

R. Mcclure, C. K. Barha, and L. Galea, 17?-Estradiol, but not estrone, increases the survival and activation of new neurons in the hippocampus in response to spatial memory in adult female rats, Horm Behav, vol.63, pp.144-157, 2013.

D. N. Bryant and D. M. Dorsa, Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity, Neuro-science, vol.170, pp.1261-1269, 2010.

P. S. Green, K. E. Gridley, and J. W. Simpkins, Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione, Neuroscience, vol.84, pp.7-10, 1998.

A. D. Mooradian, Antioxidant properties of steroids, J Steroid Biochem Mol Biol, vol.45, pp.509-511, 1993.

G. Biggio, P. Follesa, and E. Sanna, GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone, Int Rev Neurobiol, pp.46207-46241, 2001.

E. Dong, K. Matsumoto, and V. Uzunova, A Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation, Proc Natl Acad Sci U S A, vol.98, issue.5, pp.2849-2854, 2001.

L. D. Griffin and S. H. Mellon, Selective serotonin reuptakeinhibitors directly alter activity of neurosteroidogenic enzymes, Proc Natl Acad Sci U S A, vol.96, issue.23, pp.13512-13517, 1999.

I. Sundström and T. Backstrom, Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial, Psychoneuroendocrinol, vol.23, issue.1, pp.73-88, 1998.

B. J. Blyth, R. L. Hauger, R. H. Purdy, and J. A. Amico, The neurosteroid allopregnanolone modulates oxytocin expression in the hypothalamic paraventricular nucleus, Am J Physiol Regul Integr Comp Physiol, vol.278, issue.3, pp.684-691, 2000.

M. Giammanco, G. Tabacchi, and S. Giammanco, Testosterone and aggressiveness, Med Sci Monit, vol.11, issue.4, pp.136-181, 2005.

D. Dai, D. , Q. Li, and Q. Zhu, Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders Neuropsychopharmacology, vol.42, pp.2064-2071, 2017.

T. Benton, J. Staab, and D. L. Evans, Medical co-morbidity in depressive disorders, Ann. Clin. Psychiatry, vol.19, pp.289-303, 2007.

D. Goldberg, The detection and treatment of depression in the physically ill, World Psychiatry, vol.9, pp.16-20, 2010.

R. Dantzer and A. K. Walker, Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?, J. Neural. Transm, vol.121, pp.925-932, 2014.

C. Song and H. Wang, Cytokines mediated inflammation and decreased neurogenesis in animal models of depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.35, pp.760-768, 2011.

D. Brites and A. Fernandes, Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation. Fontiers in cellular neuroscience, vol.9, p.476, 2015.

N. Müller and M. Ackenheil, Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.22, pp.1-33, 1998.

R. J. Tynan, S. B. Beynon, and M. Hinwood, Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes, Acta Neuropathol, vol.126, pp.75-91, 2013.

P. Yang, Z. Gao, and H. Zhang, Changes in proinflammatory cytokines and white matter in chronically stressed rats, Neuropsychiatr. Dis. Treat, vol.11, pp.597-607, 2015.

C. A. Stockmeier and G. Rajkowska, Cellular abnormalities in depression: evidence from postmortem brain tissue, Dialogues Clin. Neurosci, vol.6, pp.185-197, 2004.

G. Rajkowska and J. J. Miguel-hidalgo, Gliogenesis and glial pathology in depression, CNS Neurol. Disord. Drug Targets, vol.6, pp.219-233, 2007.

G. Serafini, Z. Rihmer, A. , and M. , The role of glutamate excitotoxicity and neuroinflammation in depression and suicidal behavior: focus on microglia cells, Neuroimmunol Neuroinflamm, vol.2, pp.127-130, 2015.

R. Yirmiya, N. Rimmerman, and R. Reshef, Depression as a microglial disease, Trends Neurosci, vol.38, pp.637-658, 2015.

M. Hamidi, . Drevets, and P. Wc, JL Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes, Biol. Psychiatry, vol.55, pp.563-569, 2004.

L. L. Altshuler, O. A. Abulseoud, and L. Foland-ross, Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder, vol.12, pp.541-549, 2010.

F. R. Walker, M. Nilsson, and K. Jones, Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function, Curr. Drug Targets, vol.14, pp.1262-1276, 2013.

A. Nimmerjahn, F. Kirchhoff, and F. Helmchen, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, vol.308, pp.1314-1318, 2005.

H. Kettenmann, U. K. Hanisch, and M. Noda, Physiology of microglia, Physiol. Rev, vol.91, pp.461-553, 2011.

G. C. Bachstetter and A. D. , The role of microglia in adult hippocampal neurogenesis, Front. Cell. Neurosci, vol.7, p.229, 2013.

S. G. Torres-platas, C. Cruceanu, and G. G. Chen, Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides, Brain Behav. Immun, vol.42, pp.50-59, 2014.

A. Roman, G. Kreiner, and I. Nalepa, Macrophages and depression -a misalliance or wellarranged marriage?, Pharmacol. Rep, vol.65, pp.1663-1672, 2013.

H. Liu, J. Kaur, and K. Dashtipour, Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes and glucocorticosteroid level, Exp. Neurol, vol.184, pp.196-213, 2003.

C. Song and H. Wang, Cytokines mediated inflammation and decreased neurogenesis in animal models of depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.35, pp.760-768, 2011.

M. K. Borsody and J. M. Weiss, Alteration of locus coeruleus neuronal activity by interleukin-1 and the involvement of endogenous corticotropin-releasing hormone, Neuroimmunomodulation, vol.10, issue.2, pp.101-122, 2002.

M. K. Borsody and J. M. Weiss, The effects of endogenous interleukin-1 bioactivity on locus coeruleus neurons in response to bacterial and viral substances, Brain Res. 8 mai, vol.1007, issue.1-2, pp.39-56, 2004.

C. D. Breder, C. A. Dinarello, and C. B. Saper, Interleukin-1 immunoreactive innervation of the human hypothalamus, Science, pp.321-324, 1988240.

O. J. Schiepers, M. C. Wichers, and M. Maes, Cytokines and major depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.29, pp.201-217, 2005.

S. O'brien, P. Scully, and P. Fitzgerald, Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy, J. Psychiatr. Res, vol.41, pp.326-331, 2007.

C. Song, U. Halbreich, and C. Han, Imbalance between pro-and anti-inflammatory cytokines and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment, Pharmacopsychiatry, vol.42, pp.182-188, 2009.

Y. Dowlati, N. Herrmann, and . Swardfager, A meta-analysis of cytokines in major depression, Biol. Psychiatry, vol.67, pp.446-457, 2010.

Y. Liu, C. Ho, R. , and A. M. , Interleukin (IL)-6, tumour necrosis factor alpha (TNF-?) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression, J Psychiatr Res, vol.41, issue.3-4, pp.326-357, 2007.

X. Jegouzo, Diagnostic et caractérisation de la démence dans une cohorte de patients avec trouble bipolaire et d'âge moyen. Thèse présentée le 20 Octobre, 2014.

M. N. Breunis, R. W. Kupka, and W. A. Nolen, High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar dis-order, Biol, vol.53, issue.2, pp.157-165, 2003.

E. Brietzke, L. Stertz, and B. S. Fernandes, Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder, J. Affect. Disord, vol.116, issue.3, pp.214-217, 2009.

A. Modabbernia, S. Taslimi, and E. Brietzke, Cytokine alterations in bipolar dis-order: ameta-analysis of 30 studies, Biol. Psychiatry, vol.74, issue.1, pp.15-25, 2013.

B. I. Goldstein, D. E. Kemp, and J. K. Soczynska, Inflammation and the phenom-enology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J. Clin. Psychiatry, vol.70, issue.8, pp.1078-1090, 2009.

D. V. Bavaresco, M. I. Da-rosa, M. Uggioni, S. D. Ferraz, T. R. Pacheco et al., Increased inflammatory biomarkers and changes in biological rhythms in bipolar disorder: A case-control study, J Affect Disord, vol.15, issue.2020, pp.115-137

F. Dickerson, C. Stallings, A. Origoni, C. Vaughan, S. Khushalani et al., Elevated Creactive protein and cognitive deficits in individuals with bipolar disorder, J Affect Disord. 5 sept, vol.150, issue.2, pp.456-465, 2013.

O. Doganavsargil-baysal, B. Cinemre, and U. Aksoy, Levels of TNF-?, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder, Hum Psychopharmacol. mars, vol.28, issue.2, pp.160-167, 2013.

I. E. Bauer, M. C. Pascoe, and B. Wollenhaupt-aguiar, Inflammatory mediators of cognitive impairment in bipolar disorder, J Psychiatr Res. sept, vol.56, pp.18-27, 2014.

J. D. Rosenblat, E. Brietzke, and R. B. Mansur, Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder : evidence, pathophysiology and treatment implications, J Affect Disord, vol.188, pp.149-59, 2015.

M. L. Phillips and H. A. Swartz, A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research, Am J Psychiatry. août, vol.171, issue.8, pp.829-872, 2014.

K. Lin, R. Shao, R. Wang, W. Lu, W. Zou et al., Inflammation, brain structure and cognition interrelations among individuals with differential risks for bipolar disorder, Brain Behav Immun. 1 janv, vol.83, pp.192-201, 2020.

R. C. Padmos, M. Hillegers, E. M. Knijff, R. Vonk, A. Bouvy et al., A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes, Arch Gen Psychiatry. avr, vol.65, issue.4, pp.395-407, 2008.

U. Krügel, J. Fischer, and S. Radicke, Antidepressant effects of TNF-? blockade in an animal model of depression, J Psychiatr Res. 1 mai, vol.47, issue.5, pp.611-617, 2013.

S. S. Valvassori, G. C. Dal-pont, and P. T. Tonin, Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania, Pharmacol Biochem Behav, vol.183, pp.56-63, 2019.

A. Wieck, R. Grassi-oliveira, C. H. Prado, and L. B. Rizzo, Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder, Brain Behav. Immun, vol.34, pp.47-55, 2013.

D. Prado, C. H. Rizzo, L. B. Wieck, A. Lopes, R. P. Teixeira et al., Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder, 2013.

F. Landreau, P. Galeano, and L. R. Caltana, Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia, PLoS One, vol.7, issue.12, p.51068, 2012.

D. J. Griffiths, Endogenous retroviruses in the human genome sequence, Genome Biol, vol.2, issue.6, 2001.

N. Sutkowski, B. Conrad, D. A. Thorley-lawson, and B. T. Huber, Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen, Immunity, vol.15, issue.4, pp.579-89

L. B. Rizzo, L. G. Costa, R. B. Mansur, W. Swardfager, S. I. Belangero et al., The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research, Neurosci Biobehav Rev, vol.42, pp.157-69, 2014.

F. Plater, Observationum, in hominis affectibus plerisque, corpori et animo, functionum laesione, dolore, aliave molestia et vitio incommodantibus, libri tres, ad Praxeos illius tractatus tres

A. Louis, Mémoire sur les tumeurs fongueuses de la duremère. Paris, académie royal de chirurgie, 1774.

E. J. Barthélemy, C. A. Sarkiss, J. Lee, and R. K. Shrivastava, The historical origin of the term « meningioma » and the rise of nationalistic neurosurgery, J Neurosurg, vol.125, issue.5, pp.1283-90, 2016.

H. Cushing and L. Eisenhart, Meningiomas; their classification, regional behavior, life history, and surgical end result, 1938.

F. X. Ferracci, Facteurs de risque de recidive des meningiomes de grade II : analyse retrospective chez 68 patients operes au chu de Rouen. Presentee le 8 septembre 2017
URL : https://hal.archives-ouvertes.fr/dumas-01684013

K. Zulch, Histological typing of tumours of the central nervous system. World Health Organization, 1979.

M. Gonzales, The 2000 World Health Organization classification of tumours of the nervous system, J Clin Neurosci Off J Neurosurg Soc Australas. janv, vol.8, issue.1, pp.1-3, 2001.

A. Perry, S. L. Stafford, B. W. Scheithauer, V. J. Suman, and C. M. Lohse, Meningioma grading: an analysis of histologic parameters, Am J Surg Pathol, vol.21, issue.12, pp.1455-65, 1997.

A. Perry, B. W. Scheithauer, S. L. Stafford, C. M. Lohse, and P. C. Wollan, Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications, Cancer, vol.85, issue.9, pp.2046-56, 1999.

M. Simon, J. Boström, P. Koch, and J. Schramm, Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification, J Neurol Neurosurg Psychiatry. juin, vol.77, issue.6, pp.767-73, 2006.

D. N. Louis, H. Ohgaki, O. D. Wiestler, W. K. Cavenee, P. C. Burger et al., The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol (Berl). août, vol.114, issue.2, pp.97-109, 2007.

H. Cushing and L. Eisenhart, Meningiomas; their classification, regional behavior, life history, and surgical end result, 1938.

T. A. Dolecek, J. M. Propp, N. E. Stroup, and C. Kruchko, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncol, vol.14, pp.1-49, 2012.

Q. T. Ostrom, H. Gittleman, P. Farah, A. Ondracek, Y. Chen et al., CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010, Neuro-Oncol, vol.15, issue.2, pp.1-56, 2013.

L. Cea-soriano, M. Wallander, G. Rodríguez, and L. A. , Epidemiology of meningioma in the United Kingdom, Neuroepidemiology, vol.39, issue.1, pp.27-34, 2012.

W. T. Longstreth, L. K. Dennis, V. M. Mcguire, M. T. Drangsholt, and T. D. Koepsell, Epidemiology of intracranial meningioma. Cancer. 1 août, vol.72, issue.3, pp.639-687, 1993.

I. R. Whittle, C. Smith, P. Navoo, and C. D. Meningiomas, Lancet Lond Engl. 8 mai, vol.363, issue.9420, pp.1535-1578, 2004.

S. Nakasu, A. Hirano, T. Shimura, and J. F. Llena, Incidental meningiomas in autopsy study, Surg Neurol. avr, vol.27, issue.4, pp.319-341, 1987.

S. Cordera, E. Bottacchi, D. 'alessandro, G. Machado, D. et al., Epidemiology of primary intracranial tumours in NW Italy, a population based study: stable incidence in the last two decades, J Neurol. mars, vol.249, issue.3, pp.281-285, 2002.

M. J. Crowley and D. F. O'brien, Epidemiology of tumours of the central nervous system in Ireland, Ir Med J. mai, vol.86, issue.3, pp.87-95, 1993.

F. G. Davis, N. Malinski, W. Haenszel, J. Chang, J. Flannery et al., Primary brain tumor incidence rates in four United States regions, 1985-1989: a pilot study, Neuroepidemiology, vol.15, issue.2, pp.103-115, 1996.

S. Nakasu, A. Hirano, T. Shimura, and J. F. Llena, Incidental meningiomas in autopsy study, Surg Neurol. avr, vol.27, issue.4, pp.319-341, 1987.

W. Krampla, S. Newrkla, W. Pfisterer, S. Jungwirth, P. Fischer et al., Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the Transdanube Ageing Study (VITA), Cancer. 15 mars, vol.100, issue.6, pp.1208-1220, 2004.

M. W. Vernooij, M. A. Ikram, H. L. Tanghe, A. Vincent, A. Hofman et al., Incidental findings on brain MRI in the general population, N Engl J Med, vol.357, issue.18, pp.1821-1829, 2007.

J. Kuratsu, M. Kochi, and Y. Ushio, Incidence and clinical features of asymptomatic meningiomas, J Neurosurg. mai, vol.92, issue.5, pp.766-70, 2000.

S. Yano and J. Kuratsu, Kumamoto Brain Tumor Research Group. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience, J Neurosurg, vol.105, issue.4, pp.538-581, 2006.

W. T. Couldwell, Asymptomatic meningiomas, J Neurosurg, vol.105, issue.4, pp.536-543, 2006.

L. Bauchet, V. Rigau, H. Mathieu-daudé, D. Figarella-branger, D. Hugues et al., French brain tumor data bank: methodology and first results on 10,000 cases, J Neurooncol. sept, vol.84, issue.2, pp.189-99, 2007.

A. Darlix, S. Zouaoui, V. Rigau, F. Bessaoud, D. Figarella-branger et al., Erratum to: Epidemiology for primary brain tumors: a nationwide population-based study, J Neurooncol, vol.131, issue.3, p.547, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01797020

M. Bondy and B. L. Ligon, Epidemiology and etiology of intracranial meningiomas: a review, J Neurooncol. sept, vol.29, issue.3, pp.197-205, 1996.

S. Preston-martin, Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County, Neuroepidemiology, vol.8, issue.6, pp.283-95, 1989.

W. T. Longstreth, L. K. Dennis, V. M. Mcguire, M. T. Drangsholt, and T. D. Koepsell, Epidemiology of intracranial meningioma. Cancer. 1 août, vol.72, issue.3, pp.639-687, 1993.

I. R. Whittle, C. Smith, P. Navoo, and C. D. Meningiomas, Lancet Lond Engl. 8 mai, vol.363, issue.9420, pp.1535-1578, 2004.

I. S. Muskens, A. H. Wu, J. Porcel, I. Cheng, L. Marchand et al., Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: the Multiethnic Cohort, Neuro-Oncol, vol.18, issue.4, pp.498-507, 2019.

V. S. Benson, K. Pirie, J. Green, D. Casabonne, and V. Beral, Million Women Study Collaborators. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort, Br J Cancer. 8 juill, vol.99, issue.1, pp.185-90, 2008.

M. B. Ismail, C. Rousselot, and P. Francois, Meningiomes intracraniens, EMC Neurologiejanvier, 2005.

M. Sanson, A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma, Rev Neurol, vol.152, issue.1, pp.1-10, 1996.

T. Sato and Y. Sekido, NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma, Int J Mol Sci. 26 mars, vol.19, issue.4, 2018.

M. F. James, S. Han, C. Polizzano, S. R. Plotkin, B. D. Manning et al., NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth, Mol Cell Biol. août, vol.29, issue.15, pp.4250-61, 2009.

N. F. Shen, Y. Niida, and R. Beauchamp, Inactivation patterns of NF2 and DAL1/4.1B in sporadic meningioma, Cancer Gene Cytogene, vol.162, pp.135-144, 2005.

J. Ruiz, A. Martinez, and S. Hernandes, Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumor recurrence of 247 meningiomas grade I and II, Histol Histopathol, vol.25, pp.341-350, 2010.

L. Boldrini, S. Pistolesi, and S. Gisfredi, Telomerase in intracranial meningiomas, Int J Mol Med, vol.12, pp.943-950, 2003.

G. A. Alexiou, S. Markoula, P. Gogou, and A. P. Kyritsis, Genetic and molecular alterations in meningiomas, Clin Neurol Neurosurg. mai, vol.113, issue.4, pp.261-268, 2011.

M. Aavikko, S. Li, S. Saarinen, P. Alhopuro, E. Kaasinen et al., Loss of SUFU function in familial multiple meningioma, Am J Hum Genet, vol.91, issue.3, pp.520-526, 2012.

J. Minouk, A. J. Schoemaker, . Swerdlow, D. Craig, and . Higgins, Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study, Lancet Oncol, vol.9, pp.239-285, 2008.

G. Berg-beckhoff, J. Schuz, and M. Blettner, History of allergic disease and epilepsy and risk of glioma amd meningioma (interphone, study group, Germany), Eur J Epidemiol, vol.24, issue.8, pp.433-473, 2009.

E. Linos, T. Raine, and A. Alonso, Atopy and risk of brain tumors: a meta-analysis. Natl Cancer Inst, vol.99, pp.1544-50, 2007.

G. Hale, E. Davies, and D. Grindlay, What s new in atopic eczema ? An analysis of systematic reviews published in 2017: epidemiology, aetiology and risk factors, Clin Exp Dermatol, vol.44, issue.8, pp.868-873, 2019.

M. J. Schoemaker, A. J. Swerdlow, and S. J. Hepworth, History of allergic disease and risk of meningioma, Am J of Epi, vol.165, issue.5, pp.477-85, 2007.

A. V. Brenner, M. S. Linet, and H. A. Fine, History of allergies and autoimmune diseases and risk of brain tumors in adults, Int J Cancer, vol.99, issue.2, pp.252-261, 2002.

I. S. Muskens, A. H. Wu, and J. Porcel, Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: the Multiethnic Cohort Neuro Oncol, vol.21, pp.498-507, 2019.

C. Seliger, C. R. Meier, and C. Becker, Diabetes, use of metformin and the risk of meningioma. PloS One, vol.12, p.181089, 2017.

D. S. Michaud, G. Bove, and V. Gallo, Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study, Cancer Prev Res (Phila), vol.4, issue.9, pp.1385-92, 2011.

T. Niedermaier, G. Behrens, D. Schmid, I. Schlecht, B. Fischer et al., Body mass index, physical activity, and risk of adult meningioma and glioma: A meta-analysis, Neurology, vol.85, issue.15, pp.1342-50, 2015.

G. Strain, B. Zumoff, W. Rosner, and X. Pi-sunyer, The relationship between serum levels of insulin and sex hormone-binding globulin in men: the effect of weight loss, J Clin Endocrinol Metab, vol.79, issue.4, pp.1173-1179, 1994.

H. J. Schneider, B. Saller, J. Klotsche, W. März, W. Erwa et al., Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects, Eur J Endocrinol. mai, vol.154, issue.5, pp.699-706, 2006.

D. Gunnell, S. E. Oliver, J. L. Donovan, T. J. Peters, D. Gillatt et al., Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease?, J Clin Endocrinol Metab. janv, vol.89, issue.1, pp.213-221, 2004.

A. Fernández-sánchez, E. Madrigal-santillán, M. Bautista, J. Esquivel-soto, A. Morales-gonzález et al., Inflammation, oxidative stress, and obesity, Int J Mol Sci, vol.12, issue.5, pp.3117-3149, 2011.

B. T. Ragel, R. L. Jensen, and W. T. Couldwell, Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors, Neurosurg Focus, vol.23, issue.4, p.7, 2007.

P. D. Inskip, L. Mellemkjaer, G. Gridley, and J. H. Olsen, Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control CCC, janv, vol.9, issue.1, pp.109-125, 1998.

L. E. Phillips, T. D. Koepsell, G. Van-belle, W. A. Kukull, J. Gehrels et al., History of head trauma and risk of intracranial meningioma: population-based case-control study, Neurology. 25 juin, vol.58, issue.12, pp.1849-52, 2002.

S. Preston-martin, A. Paganini-hill, B. E. Henderson, M. C. Pike, and C. Wood, Case-control study of intracranial meningiomas in women in, J Natl Cancer Inst. juill, vol.65, issue.1, pp.67-73, 1980.

R. T. Parker, C. A. Ovens, C. L. Fraser, and C. Samarawickrama, Optic nerve sheath meningiomas: prevalence, impact, and management strategies, Eye Brain, vol.10, pp.85-99, 2018.

J. F. Annegers, E. R. Laws, L. T. Kurland, and J. D. Grabow, Head trauma and subsequent brain tumors, Neurosurgery. mars, vol.4, issue.3, pp.203-209, 1979.

N. W. Choi, L. M. Schuman, and W. H. Gullen, Epidemiology of primary central nervous system neoplasms. II. Case-control study, Am J Epidemiol. mai, vol.91, issue.5, pp.467-85, 1970.

M. P. Berleur and S. Cordier, The role of chemical, physical, or viral exposures and health factors in neurocarcinogenesis: implications for epidemiologic studies of brain tumors, Cancer Causes Control CCC. mai, vol.6, issue.3, pp.240-56, 1995.

G. Gosztonyi and F. Slowik, Intracranial meningiomas developing at long intervals following low-dose X-ray irradiation of the head, J Neurooncol, vol.70, issue.1, pp.59-65, 2004.

B. E. Claus, L. Calvocoressi, and M. L. Bondy, Dental x-rays and risk of meningioma, vol.118, pp.4530-4537, 2012.

A. Navas-acién, M. Pollán, P. Gustavsson, B. Floderus, N. Plato et al., Interactive effect of chemical substances and occupational electromagnetic field exposure on the risk of gliomas and meningiomas in Swedish men, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. déc, vol.11, issue.12, pp.1678-83, 2002.

S. Lönn, A. Ahlbom, P. Hall, M. Feychting, and S. Group, Long-term mobile phone use and brain tumor risk, Am J Epidemiol. 15 mars, vol.161, issue.6, pp.526-561, 2005.

A. Lahkola, K. Tokola, and A. Auvinen, Meta-analysis of mobile phone use and intracranial tumors, Scand J Work Environ Health. juin, vol.32, issue.3, pp.171-178, 2006.

M. Hours, M. Bernard, L. Montestrucq, M. Arslan, A. Bergeret et al., Cell Phones and Risk of brain and acoustic nerve tumours: the French INTERPHONE case-control study

, Rev Epidemiol Sante Publique, vol.55, pp.321-353, 2007.

A. F. Weiss, R. Portmann, H. Fischer, J. Simon, and K. D. Zang, Simian virus 40-related antigens in three human meningiomas with defined chromosome loss, Proc Natl Acad Sci U S A. févr, vol.72, issue.2, pp.609-622, 1975.

M. Fiori, D. Mayorca, and G. , Occurrence of BK virus DNA in DNA obtained from certain human tumors, Proc Natl Acad Sci U S A. déc, vol.73, issue.12, pp.4662-4668, 1976.

H. Ibelgaufts and K. W. Jones, Papovavirus-related RNA sequences in human neurogenic tumours, Acta Neuropathol (Berl), vol.56, issue.2, pp.118-140, 1982.

M. S. Motebejane, I. Kaminsky, and B. C. Enicker, Intracranial Meningiomas in the Era of Human Immunodeficiency Virus Infection and Antiretroviral Therapies, Neurosurgery, vol.64, pp.97-104, 2017.

C. M. Samanic, A. J. De-roos, P. A. Stewart, P. Rajaraman, M. A. Waters et al., Occupational exposure to pesticides and risk of adult brain tumors, Am J Epidemiol. 15 avr, vol.167, issue.8, pp.976-85, 2008.

C. Piel, C. Pouchieu, S. Tual, L. Migault, C. Lemarchand et al., Central nervous system tumors and agricultural exposures in the prospective cohort AGRICAN, Int J Cancer, vol.01, issue.9, pp.1771-82, 2017.

L. E. Phillips, W. T. Longstreth, T. Koepsell, B. S. Custer, W. A. Kukull et al., Active and passive cigarette smoking and risk of intracranial meningioma, Neuroepidemiology, vol.24, issue.3, pp.117-139, 2005.

E. B. Claus, K. M. Walsh, L. Calvocoressi, M. L. Bondy, J. M. Schildkraut et al., Cigarette smoking and risk of meningioma: the effect of gender, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. juin, vol.21, issue.6, pp.943-50, 2012.

B. Vs, K. Pirie, and J. Green, Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort, Br J Cancer, vol.99, issue.1, pp.185-90, 2008.

B. T. Hawkins, R. C. Brown, and T. P. Davis, Smoking and ischemic stroke: a role for nicotine?, Trends Pharmacol Sci. févr, vol.23, issue.2, pp.78-82, 2002.

H. Boeing, . Schlehofer, and M. Blettner, Dietary carcinogens and the risk for glioma and meningioma in Germany, Int J Cancer, vol.53, issue.4, pp.561-566, 1993.

B. Malmer, H. Gronbergs, and A. T. Bergenheim, Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study, Int J Cancer, vol.81, issue.3, pp.366-70, 1999.

K. Hemminki and X. Li, VaittinenP> Cancers in the firt-degree relatives of children with brain tumours, BR J Cancer, vol.83, issue.3, pp.407-411, 2000.

J. L. Schmutz, Cyproterone acetate and meningioma: The latest findings

, Ann Dermatol Venereol, vol.145, issue.5, pp.390-391, 2018.

K. Korhonen, T. Salminen, and J. Raitanen, Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression, J Neurooncol, vol.80, issue.1, pp.1-7, 2006.

A. Cowppli-bony, G. Bouvier, and M. Rue, Brain tumors and hor-monal factors: review of the epidemiological literature, Cancer Causes Control, vol.22, pp.697-714, 2011.

G. Cossu, M. Levivier, and T. D. Roy, The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature, Biomed Res Int, p.267831, 2015.

A. Supartoto, M. B. Sasongko, and D. Respatika, Relationships Between Neurofibromatosis-2, Progesterone Receptor Expression, the Use of Exogenous Progesterone, and Risk of Orbitocranial Meningioma in Females. Front Omcol, vol.8, p.651, 2009.

V. S. Benson, K. Pirie, J. Green, and D. Bull, Million Women Study Collaborators (2010) Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study, Int J Cancer, vol.127, pp.1692-1698

K. Korhonen, A. Auvinen, and H. Lyytinen, A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland, Am J Epidemiol, vol.175, pp.309-314, 2012.

, Rapport et d'Enquête concernant les méningiomes et l'acétate de cyprotérone ACETATE DE CYPROTERONE ET RISQUE DE MENINGIOME Présentée en Comité technique de pharmacovigilance le 18 juin, 2019.

S. Goutagny, A. B. Bah, and D. Henin, Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features, Neurooncology, vol.14, issue.8, pp.1090-1096, 2012.

H. Huang, R. Buhl, H. H. Hugo, and H. M. Mehdorn, Clinical and histological features of multiple meningiomas compared with solitary meningiomas, Neurol Res, vol.27, issue.3, pp.324-356, 2005.

W. Neussm and H. Hänselm, Clinicalandlaboratoryfindings in patients with multiple meningiomas, Br J Neurosurg, vol.2, issue.2, pp.249-56, 1988.

A. P. Stangl, R. Wellenreuther, D. Lenartz, J. A. Kraus, A. G. Menon et al., Clonality of multiple meningiomas, J Neurosurg, vol.86, issue.5, pp.853-861, 1997.

G. Butti, R. Assietti, R. Casalone, and P. Paoletti, Multiple meningiomas: a clinical, surgical, and cytogenetic analysis, Surg Neurol. avr, vol.31, issue.4, pp.255-60, 1989.

A. Supartoto, I. T. Mahayana, D. S. Heriyanto, M. B. Sasongko, H. D. Respatika et al., Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma, Int J Ophthalmol, vol.12, issue.4, pp.571-577, 2019.

M. J. Riemenschneider, A. Perry, and G. Reifenberger, Histological classification and molecular genetics of meningiomas, Lancet Neurol. déc, vol.5, issue.12, pp.1045-54, 2006.

A. Seyve and F. Ducray, Manifestations psychiatriques des tumeurs cérébrales : approche clinique et thérapeutique

R. K. Gupta and R. Kumar, Benign brain tumours and psychiatric morbidity : a 5 years retrospective data analysis. Australian and new zealand journal of psychiatry, vol.38, pp.316-319, 2004.

A. Rooney and R. Grant, Pharmacological treatment of depression in patients with a primary brain tumour, Cochrane Database Syst Rev, issue.5, p.6932, 2010.

F. W. Boele, A. G. Rooney, R. Grant, and M. Klein, Psychiatric symptoms in glioma patients: from diagnosis to management, Neuropsychiatr Dis Treat, vol.11, pp.1413-1433, 2015.

S. Madhusoodanan, D. Danan, and M. D. , Psychiatric manifestations of brain tumors: diagnostic implications, Expert Rev Neurother, vol.7, pp.343-352, 2007.

Y. Lampl, Y. Barak, and I. Sravo-pinchas, Intracranial meningiomas: correlation of peritumoral edema and psychiatric disturbances, Psychiatry Res, vol.58, issue.2, pp.177-80, 1995.

S. Finger, Oriogins of neuroscience : a history of explorations into brain function, 1994.

D. Blumer and D. F. Benson, Personality changes with frontal and temporal lobe lesions> NY, 1975.

L. Septien, R. Didi-roy, and J. L. Pelletier, Value of local cerebral hypoperfusion in the diagnosis of frontal syndromes. Expert assessment of head injuries, vol.19, pp.249-55, 1993.

R. G. Robinson, Mood disordes secondary to stroke, Semin Clin Neuropsychiatry, vol.2, issue.4, pp.244-251, 1997.

S. Se, R. G. Robinson, and T. R. Price, Comparaison of cortical and subcortical lesions in the production of posttroke mood disorders, Brain, vol.110, pp.1045-59, 1987.

D. Laplane and B. Buboids, Affective disorders due to the loss of mental self-activation. Comparison with athymhormia, Rev Neurol, vol.154, issue.1, pp.35-44, 1998.

M. Habib, M. L. Royere, and G. Habib,

, Arch Mal Coeur Vaiss, vol.84, pp.1225-1255, 1991.

R. Levy and B. Dubois, Apathy and the functional anatomy of the prefrontal cortex-basal circuits, Cereb Cortex, vol.16, issue.7, pp.916-944, 2006.

R. Levy and V. Czernecki, Apathy and the basal ganglia, Neurol, vol.253, pp.54-61, 2006.

H. Damasio, T. Grabowski, and R. Frank, The return of Phineas Gage: clues about the brain from the skull of a famous patient, Science, vol.264, issue.5162, pp.1102-1107, 1994.

P. J. Eslinger and A. R. Damasio, Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR, Neurology, vol.35, issue.12, pp.1731-1772, 1985.

P. Malloy, A. Bihrle, and C. Cimino, The orbitomedial frontal syndrome, Arch Clin Neuropsychol, vol.8, issue.3, pp.185-201, 1993.

C. A. Meyers and B. Sa, Scheibel RS> Case report : acquised antisocial personality disorder associated with unilateral left orbital frontal lobe damage, Journal of psychiatry and neuroscience, vol.17, pp.122-125, 1992.

K. I. Schuman and N. Herrmann, Bipolar disorder in old age, Can Fam Physican, vol.45, pp.1229-1266, 1999.

G. Gainotti, Emotional behavior and hemispheric side of the lesion, Cortex, vol.8, issue.1, pp.41-55, 1972.

F. Gallan, V. Perret, and E. Isabelle,

, Psychol Neuropsychiatr Vieil, vol.3, issue.2, pp.115-138, 2005.

A. R. Davidson, Anteriro cerebral saymmetry and the nature of emotion. Brai and cognition, vol.20, pp.125-151, 1992.

. Folstein-mf, . Maiberger-r, and . Mchugh-pr, Mood disorder as a specific complication of stroke, Neurosurgery and Psychiatry, vol.40, pp.1018-1020, 1977.

J. P. Sinyor-d, K. Dg, . Becker-r, C. Goldenberg-m, and . Hm, Poststroke depression and lesion location: an attempted replication, Brain, vol.109, pp.537-546, 1986.

, KLEIN M Contribution à l étude de la génèse des etats maniaco depressifs 1935 PAYOT ed essais de psychanalyse

L. Legoues-g-le-psychanalyste and . Vieillard, , 1991.

A. Nanda, S. C. Bir, S. Konar, T. Maiti, P. Kalakoti et al., Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence, J Clin Neurosci, vol.31, pp.112-133, 2016.

A. Durand, F. Labrousse, A. Jouvet, L. Bauchet, M. Kalamarides et al., WHO grade II and III meningiomas: a study of prognostic factors, J Neurooncol, vol.95, issue.3, pp.367-75, 2009.

L. A. Rosenberg, R. A. Prayson, J. Lee, C. Reddy, S. T. Chao et al., Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution, diat Oncol Biol Phys, vol.74, issue.2, pp.427-459, 2009.

D. Simpson, The recurrence of intracranila meningiomas after surgical treatment, J Neurol Neurosurg Paychiatry, vol.20, pp.22-39, 1957.

R. O. Mirimanoff, D. E. Dosoretz, and R. M. Linggood, Meningioma : analysis of recurrence and progression following neurosurgical resection, J Neurosurg, vol.62, pp.18-24, 1985.

A. Nanda, S. C. Bir, S. Konar, T. Maiti, P. Kalakoti et al., Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence, J Clin Neurosci, vol.31, pp.112-133, 2016.

S. Nakasu, Y. Nakasu, and M. Nakajima, Preoperative identification of menngiomas that are highty likely to recur, J Neurosurg, vol.90, pp.455-62, 1999.

L. Palma, P. Celli, and C. Franco, Long term prognosis for atypical and malignant meningiomas : a study of 71surgical cases, J Neurosurg, vol.86, pp.793-800, 1997.

H. Kamitani and H. Masuzawa, Kanazawa I Recurrence of convexity meningiomas: tumor cells in the arachnoid membrane, Surg Neurol, vol.56, issue.4, pp.228-263, 2001.

P. H. Aguiar, A. M. Tsanaclis, and T. , Proliferation rate of intracranial meningiomas as defined by monoclonal antibody MIB-! : correlation with peritu;oral oedema and other clinicoradiological and histological caracteristics, Neurosurg Rev, vol.26, pp.221-229, 2003.

K. Kakimuna, R. Tanaka, and K. Onda, Proliferative potential of recurrent intracranial meningiomasas evuated by labelling indices of BUdr and Ki-67

, Acta Neurochir, vol.140, pp.26-32, 1988.

E. Pressman, D. Penn, and N. J. Patel, Intracranial Hemorrhage from Meningioma: 2 Novel Risk Factors, World Neurosurg. mars, vol.135, pp.217-238, 2020.

C. Renoux, S. Vahey, S. Dell'aniello, and J. Boivin, Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage, JAMA Neurol, vol.01, issue.2, pp.173-80, 2017.

D. G. Hackam and M. Mrkobrada, Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology, vol.79, pp.1862-1867, 2012.

R. Verhegffgen, M. Finkenstaedt, and V. Bockermann, Atypical and magignant meningiomas : evaluation of different radiological criteria based on CT and MRI, Acta Neurochir Suppl, vol.65, pp.66-75, 1996.

T. Litchtor, H. Yamamoto, and M. E. Gurney, Gene Expression of Neurotrophic Factors in Human Brain Tumors. Moleculqr and cellular neurosciences, vol.2, pp.168-171, 1991.

M. Hofer and S. R. Pagliusi, Holn A> regional distribution of brain derived neurotrophic factor mRNA in the adult mouse brain, EMBO J, vol.9, issue.8, pp.2459-64, 1990.

M. Westermann, D. K. Meyer, and P. Ehrhrds, Neuronotrophic factors released By C6 glioma Cells, J Neurochem, vol.50, issue.6, pp.1747-58, 1988.

P. M. Richardson and V. M. Issa, Riopelle RJ> Distribution of neuronal receptors fr nerve growth facto rn the rat, J Neurosci, vol.6, issue.8, pp.2312-2333, 1986.

G. Reifenberger, R. Prior, and M. Deckert, Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system, Virchows Arch A Pathol Anat Histopathol, vol.414, issue.2, pp.147-55, 1989.

M. Westphal and H. D. Herrmann, Epidermal growth factor--receptors on cultured human meningioma cells, Acta Neurochir (Wien), vol.83, issue.1-2, pp.62-68, 1986.

A. S. Weissman, S. S. Raguet, and P. A. Kelly, Characterization of the epidermal growth factor receptor in human meningioma, Cancer Res, vol.15, issue.8, pp.2172-2178, 1987.

H. E. Boyle-walsh and V. Speirs, Intreleukin-6 (IL-6) production and cell growth of cultured human ameningiomas : interactions with interleukin-1B (IL-1B) and interleukin-4 (IL-4) in vitro, Neuroscience letters, vol.170, pp.129-132, 1994.

M. Johnson, C. F. Federspiel, and L. I. Gold, Transforming Growth Factor-r3 and Transforming Growth Factor receptor

M. Berhouma, T. Jacquesson, and E. F. Cotton, Pathogenesis of peri-tumoral edema in intracranial meningiomas, Neurosurg Rev, vol.42, issue.1, pp.59-71, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01919580

K. G. Go, J. T. Wilmink, and W. M. Molenaar, Peritumoral brain edema associated with meningiomas, Neurosurgery, vol.23, pp.175-179, 1988.

J. Hou, V. R. Kshettry, W. R. Selman, and N. C. Bambakidis, Peritumoral brain edema in intracranial meningiomas: the emer-gence of vascular endothelial growth factor-directed therapy, Neurosurg Focus, vol.35, p.2, 2013.

A. Simis, P. H. Pires-de-aguiar, C. C. Leite, P. A. Santana, S. Rosemberg et al., Peritumoral brain edema in benign menin-giomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence, Surg Neurol, vol.70, pp.471-477, 2008.

P. Dharmalingam, R. Kumar, V. R. Verma, and S. K. , Vascular endothelial growth factor expression and angiogenesis in various grades and subtypes of meningioma, Indian J Pathol Microbiol, vol.56, pp.349-354, 2013.

J. C. Tsai, Y. Y. Hsiao, L. J. Teng, C. T. Shun, C. T. Chen et al., Regulation of vascular endothelial growth factor secretion in human meningioma cells, J Formos Med Assoc, vol.98, pp.111-117, 1999.

E. F. Adams and . Todo, TAutocrine control of human meningioma proliferation: secretion of platelet-derived growth-factor-like molecules, Int J Cancer, vol.49, issue.3, pp.398-402, 1991.

S. A. Shamsdin, A. Mehrafshan, and S. Mohammad, Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran, Asian Pac J Cancer Prev, vol.20, issue.10, pp.2883-2890, 2019.

T. Todo and A. Ef, Secretion of interleukin-6 by human meningioma cells: possibleautocrine inhibitory regulation of neoplastic cell growth, Neurosurg, vol.81, issue.3, pp.394-401, 1994.

E. Boyle-walsh, I. A. Hashim, and V. Speirs, Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas:-interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro, Neurosci Lett, vol.170, issue.1, pp.129-161, 1994.

A. M. Buccoliero, F. Castglione, and . Degl'innocenti, Cyclooxygenase-2 (COX-2) overexpression in meningiomas: real time PCR and immunohistochemistry, Appl Immunohistochem Mol Morphol, vol.15, issue.2, pp.187-92, 2007.

F. P. Giraldi, M. R. Terrioni, and C. Andreoti, Meningioma Presenting with Cushing's Syndrome: An Unusual. Clinical Presentation, Ann Neurol, vol.53, pp.138-142, 2003.

Y. Hirota, O. Tachibana, and N. Uchiyama, Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas, Clinical neurology and neurosurgery, vol.111, pp.127-133, 2009.

T. Anda, M. Honda, and T. Ishirara, Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: case report, Neurol Med Chir (Tokyo), vol.54, issue.4, pp.327-357, 2014.

Q. Li, H. Coulson, and Z. Klaassen, Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningioma, Prostate Cancer Prostatic Dis, vol.16, issue.4, pp.387-90, 2013.

E. Boyle-walsh, M. Shenkin, W. White, and . Fraser, Effect of glycoprotein and protein hormones on human meningioma cell proliferation in vitro, J Endocrinol, 1995.

K. Korhonen, T. Salminen, and J. Raitanen, Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression, J Neurooncol, vol.80, issue.1, pp.1-7, 2006.

M. Bolanowski, J. Schopohl, and M. Marciniak, Acromegaly due to GHRH-secreting large bronchial carcinoid. Complete recovery following tumor surgery, Exp Clin Endocrinol Diabetes, vol.110, issue.4, pp.188-92, 2002.

L. Curto, S. Squadrito, and B. Almoto, MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case, Pituitary, vol.10, pp.299-305, 2007.

B. C. Patterson, C. Yan, and C. A. Sklar, Growth Hormone Exposure as a Risk Factor for the Development of Subsequent Neoplasms of the Central Nervous System: A Report From the Childhood Cancer Survivor Study, J Clin Endocrinol Meta, vol.99, issue.6, pp.2030-2037, 2014.

H. M. Khandwada, I. E. Mccutcheron, and A. Flyvbnerg, The effects of insulin-like growth factors on tumorigenesis and neoplastic growth, Endocr Rev, vol.21, issue.3, pp.215-259, 2000.

H. Zhu, Y. Miao, and Y. Shen, The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma, Transl Med, vol.17, issue.1, p.354, 2019.

G. Muccioli, C. Ghe, and G. Faccani, Prolactin receptors in human meningiomas: characterization and biological role, J Endocrinol, vol.153, issue.3, pp.365-71, 1997.

E. Ciccarelli, P. Razzore, and D. Gaia, Hyperprolactinaemia and prolactin binding in benign intracranial tumours, J Neurosurg Sci, vol.45, issue.2, pp.70-74, 2001.